<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="pmc-domain-id">440</journal-id><journal-id journal-id-type="pmc-domain">plosone</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>PLOS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10491005</article-id><article-id pub-id-type="pmcid-ver">PMC10491005.1</article-id><article-id pub-id-type="pmcaid">10491005</article-id><article-id pub-id-type="pmcaiid">10491005</article-id><article-id pub-id-type="pmid">37682909</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0274276</article-id><article-id pub-id-type="publisher-id">PONE-D-22-23382</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Mathematical and Statistical Techniques</subject><subj-group><subject>Statistical Methods</subject><subj-group><subject>Forecasting</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics</subject><subj-group><subject>Statistical Methods</subject><subj-group><subject>Forecasting</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Endocrinology</subject><subj-group><subject>Endocrine Disorders</subject><subj-group><subject>Diabetes Mellitus</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Metabolic Disorders</subject><subj-group><subject>Diabetes Mellitus</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Cancer Detection and Diagnosis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer Detection and Diagnosis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and Neoplasms</subject><subj-group><subject>Colorectal Cancer</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Mental Health and Psychiatry</subject><subj-group><subject>Dementia</subject><subj-group><subject>Alzheimer's Disease</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Neurology</subject><subj-group><subject>Dementia</subject><subj-group><subject>Alzheimer's Disease</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Neurodegenerative Diseases</subject><subj-group><subject>Alzheimer's Disease</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Neurology</subject><subj-group><subject>Neurodegenerative Diseases</subject><subj-group><subject>Alzheimer's Disease</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>Medical Risk Factors</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Research Assessment</subject><subj-group><subject>Systematic Reviews</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>A systematic review of clinical health conditions predicted by machine learning diagnostic and prognostic models trained or validated using real-world primary health care data</article-title><alt-title alt-title-type="running-head">Machine learning prediction models in primary health care</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4529-7114</contrib-id><name name-style="western"><surname>Abdulazeem</surname><given-names initials="H">Hebatullah</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3311-9804</contrib-id><name name-style="western"><surname>Whitelaw</surname><given-names initials="S">Sera</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schauberger</surname><given-names initials="G">Gunther</given-names></name><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3523-1362</contrib-id><name name-style="western"><surname>Klug</surname><given-names initials="SJ">Stefanie J.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Chair of Epidemiology, Department of Sport and Health Sciences, Technical University of Munich (TUM), Munich, Germany</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada</addr-line></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Vathy-Fogarassy</surname><given-names initials="&#xC1;">&#193;gnes</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of Pannonia: Pannon Egyetem, HUNGARY</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>hebatullah.abdulazeem@tum.de</email></corresp></author-notes><pub-date pub-type="epub"><day>8</day><month>9</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>18</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">444545</issue-id><elocation-id>e0274276</elocation-id><history><date date-type="received"><day>23</day><month>8</month><year>2022</year></date><date date-type="accepted"><day>29</day><month>8</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>08</day><month>09</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>09</day><month>09</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-09-11 06:25:21.203"><day>11</day><month>09</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 Abdulazeem et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Abdulazeem et al</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="pone.0274276.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="pone.0274276.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="editor-report" xml:lang="en" ext-link-type="doi" xlink:href="10.1371/journal.pone.0274276"><pub-id pub-id-type="doi">10.1371/journal.pone.0274276</pub-id></related-article><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="reviewed-article" xml:lang="en" ext-link-type="doi" xlink:href="10.1371/journal.pone.0274276"><pub-id pub-id-type="doi">10.1371/journal.pone.0274276</pub-id></related-article><abstract><p>With the advances in technology and data science, machine learning (ML) is being rapidly adopted by the health care sector. However, there is a lack of literature addressing the health conditions targeted by the ML prediction models within primary health care (PHC) to date. To fill this gap in knowledge, we conducted a systematic review following the PRISMA guidelines to identify health conditions targeted by ML in PHC. We searched the Cochrane Library, Web of Science, PubMed, Elsevier, BioRxiv, Association of Computing Machinery (ACM), and IEEE Xplore databases for studies published from January 1990 to January 2022. We included primary studies addressing ML diagnostic or prognostic predictive models that were supplied completely or partially by real-world PHC data. Studies selection, data extraction, and risk of bias assessment using the prediction model study risk of bias assessment tool were performed by two investigators. Health conditions were categorized according to international classification of diseases (ICD-10). Extracted data were analyzed quantitatively. We identified 106 studies investigating 42 health conditions. These studies included 207 ML prediction models supplied by the PHC data of 24.2 million participants from 19 countries. We found that 92.4% of the studies were retrospective and 77.3% of the studies reported diagnostic predictive ML models. A majority (76.4%) of all the studies were for models&#8217; development without conducting external validation. Risk of bias assessment revealed that 90.8% of the studies were of high or unclear risk of bias. The most frequently reported health conditions were diabetes mellitus (19.8%) and Alzheimer&#8217;s disease (11.3%). Our study provides a summary on the presently available ML prediction models within PHC. We draw the attention of digital health policy makers, ML models developer, and health care professionals for more future interdisciplinary research collaboration in this regard.</p></abstract><funding-group><funding-statement>The authors received no specific funding for this work.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="4"/><page-count count="25"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its <xref rid="sec020" ref-type="sec">Supporting information</xref> files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its <xref rid="sec020" ref-type="sec">Supporting information</xref> files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Primary health care (PHC) is considered the gatekeeper, where health education and promotion are provided, non-life-threatening health conditions are diagnosed and treated, and chronic diseases are managed [<xref rid="pone.0274276.ref001" ref-type="bibr">1</xref>]. This form of health maintenance, which aims to provide constant access to high-quality care and comprehensive services, is defined and called for by the World Health Organization (WHO) global vision for PHC [<xref rid="pone.0274276.ref002" ref-type="bibr">2</xref>]. Clinicians&#8217; skills and experience and the further continuing professional development are fundamental to achieve these PHC aims [<xref rid="pone.0274276.ref003" ref-type="bibr">3</xref>]. Additional health care improvement can be achieved by capitalizing on digital health and AI technologies.</p><p>With the high number of patients visiting PHC and the emergence of electronic health records, substantial amounts of data are generated on daily basis. A wide spectrum of data analytics exist to utilize such data; however, meaningful interpretation of large complicated data may not be adequately handled by traditional data analytics [<xref rid="pone.0274276.ref004" ref-type="bibr">4</xref>]. Tools that could more accurately predict diseases incidence and progression and offer advice on adequate treatment could improve the decision-making process. Machine Learning (ML), a subtype of Artificial Intelligence (AI), provides methods to productively mine this large amount of data such as predictive models that potentially forecast and predict diseases occurrence and progression [<xref rid="pone.0274276.ref005" ref-type="bibr">5</xref>]. The variety of ML prediction models&#8217; characteristics provide broader opportunities to support the healthcare practice.</p><p>Integrating PHC with updated technologies allows for the coordination of numerous disciplines and views. Integrating PHC with such technologies allows for improvements in health care, which may include patient care outcomes and productivity and efficiency within health care facilities [<xref rid="pone.0274276.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0274276.ref006" ref-type="bibr">6</xref>]. ML models have been developed in health research&#8211;most significantly in the last decade&#8212;to predict the incidence of diabetes, cancers, and recently COVID-19 pandemic related illness from health records [<xref rid="pone.0274276.ref007" ref-type="bibr">7</xref>]. A systematic overview of 35 studies published in 2021 investigated the existing literature of AI/ML, but exclusively in relation to WHO indicators [<xref rid="pone.0274276.ref008" ref-type="bibr">8</xref>]. Other literature and scoping reviews examined AI/ML in relation to certain health conditions, such as HIV [<xref rid="pone.0274276.ref009" ref-type="bibr">9</xref>], hypertension [<xref rid="pone.0274276.ref010" ref-type="bibr">10</xref>], and diabetes [<xref rid="pone.0274276.ref011" ref-type="bibr">11</xref>]. Other systematic reviews targeted specific health conditions across multiple health sectors, such as pregnancy care [<xref rid="pone.0274276.ref012" ref-type="bibr">12</xref>], melanoma [<xref rid="pone.0274276.ref013" ref-type="bibr">13</xref>], stroke [<xref rid="pone.0274276.ref014" ref-type="bibr">14</xref>], and diabetes [<xref rid="pone.0274276.ref015" ref-type="bibr">15</xref>]. However, reviews investigating PHC specifically have been fewer [<xref rid="pone.0274276.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0274276.ref017" ref-type="bibr">17</xref>]. It has been reported that research on ML for PHC stands at an early stage of maturity [<xref rid="pone.0274276.ref017" ref-type="bibr">17</xref>]. Similar to ours, a recently published protocol of a systematic review addressing the performance of ML prediction models in multiple different medical fields was published [<xref rid="pone.0274276.ref018" ref-type="bibr">18</xref>]. However, this protocol does not focus specifically on primary care and its search is limited to the years 2018 and 2019. Hence, the current literature is not enough to identify what diseases are targeted by ML prediction models within real-world PHC. Furthermore, literature investigating the validity and the potential impact of such models are not abundant. To direct the focus toward this gap, we conducted this systematic review to encompass the health conditions predicted through using ML models within PHC settings.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><p>We conducted a systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [<xref rid="pone.0274276.ref019" ref-type="bibr">19</xref>] and the CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies (CHARMS) [<xref rid="pone.0274276.ref020" ref-type="bibr">20</xref>]. The protocol for our review was registered on PROSPERO CRD42021264582 [<xref rid="pone.0274276.ref021" ref-type="bibr">21</xref>].</p><sec id="sec003"><title>Search strategy and selection criteria</title><p>A comprehensive and systematic search was performed covering multidisciplinary databases: 1. Cochrane Library, 2. Elsevier (including ScienceDirect, Scopus, and Embase), 3. PubMed, 4. Web of Science (including nine databases), 5. BioRxiv and MedRxiv, 6. Association for Computer Machinery (ACM) Digital Library, and 7. Institute of Electrical and Electronics Engineers (IEEE) Xplore Digital Library.</p><p>To find potentially relevant studies, we searched literature with the last updated search on January 4, 2022, back to January 1, 1990. The utilized search terms included "machine learning", "artificial intelligence", "deep learning", and "primary health care". Boolean operators and symbols were adapted to each literature database. Hand searches of citations of relevant reviews and a cross-reference check of the retrieved articles were also performed. Conference abstracts and gray literature searches were conducted using the available features of some databases. The full search strategy for all the electronic databases is presented in <xref rid="pone.0274276.s003" ref-type="supplementary-material">S1 File</xref>. A reference management software (EndNote X9) was used to import references and to remove duplicates.</p><p>The inclusion criteria were as follows: primary research articles (peer-reviewed, preprint, or abstract) without language restriction, studies reporting AI, DL or ML prediction models for any health condition within PHC settings, and using real-world PHC data, either exclusive or linked to other health care data. We directed our focus toward these supervised ML models (random forest, support vector machine (SVM), boosting models, decision tree, na&#239;ve bias, least absolute shrinkage and selection operator (LASSO), and k-nearest neighbors) and the neural networks.</p></sec><sec id="sec004"><title>Literature screening, data collection and statistical analysis</title><p>Title and abstract screening for all records were conducted independently by two researchers through the Rayyan platform [<xref rid="pone.0274276.ref022" ref-type="bibr">22</xref>]. Discrepancies were resolved by discussion. All studies that met the eligibility criteria were included in the systematic review. The process of data extraction was performed by two authors. Items and definitions of extracted data is presented in <xref rid="pone.0274276.t001" ref-type="table">Table 1</xref>.</p><table-wrap position="float" id="pone.0274276.t001" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0274276.t001</object-id><label>Table 1</label><caption><title>Items and definitions for data extraction.</title></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0274276.t001g" position="float" orientation="portrait" xlink:href="pone.0274276.t001.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Item Extracted</th><th align="center" rowspan="1" colspan="1">Definition</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1">
<bold>Meta-data</bold>
</td><td align="justify" rowspan="1" colspan="1">First author and year of publication</td></tr><tr><td align="justify" rowspan="1" colspan="1">
<bold>Study Type</bold>
</td><td align="justify" rowspan="1" colspan="1">According to CHARMS guidelines [<xref rid="pone.0274276.ref020" ref-type="bibr">20</xref>], the types of a prediction modelling studies are:<list list-type="order"><list-item><p>model development without external validation,</p></list-item><list-item><p>model development with external validation, or</p></list-item><list-item><p>external validation of a predeveloped model with or without model update.</p></list-item></list><break/><p>The included studies are presented in the Results section in three tables categorized according to these three types.</p></td></tr><tr><td align="justify" rowspan="1" colspan="1">
<bold>Study design</bold>
</td><td align="justify" rowspan="1" colspan="1">Design of the included studies.</td></tr><tr><td align="justify" rowspan="1" colspan="1">
<bold>Models purpose</bold>
</td><td align="justify" rowspan="1" colspan="1">
<list list-type="order"><list-item><p>Incident diagnostic (occurrence probability of a disorder),</p></list-item><list-item><p>Prevalent diagnostic (identifying overlooked cases), or</p></list-item><list-item><p>Prognostic (occurrence probability of a future event).</p></list-item></list>
</td></tr><tr><td align="justify" rowspan="1" colspan="1">
<bold>Country</bold>
</td><td align="justify" rowspan="1" colspan="1">Countries, from which health data were collected to train, test, or validate the models.</td></tr><tr><td align="justify" rowspan="1" colspan="1">
<bold>Source of data</bold>
</td><td align="justify" rowspan="1" colspan="1">This represents the source of the health data used to train, test, or validate the model.<list list-type="order"><list-item><p>PHC (Data exclusively originated from a PHC settings)</p></list-item><list-item><p>Linked data (PHC data linked to other data sources, such as secondary or tertiary health care)</p></list-item></list></td></tr><tr><td align="justify" rowspan="1" colspan="1">
<bold>Sample size</bold>
</td><td align="justify" rowspan="1" colspan="1">Number of the population, whom health data were used to train, test, or validate the models.</td></tr><tr><td align="justify" rowspan="1" colspan="1">
<bold>Time span of data</bold>
</td><td align="justify" rowspan="1" colspan="1">Time period, in which the health care data used for modelling were originally available in the health care system.</td></tr><tr><td align="justify" rowspan="1" colspan="1">
<bold>Health condition</bold>
</td><td align="justify" rowspan="1" colspan="1">Health condition addressed in the included studies.</td></tr></tbody></table></alternatives></table-wrap><p>Health conditions extracted were categorized according to the International Classification of Diseases (ICD)-10 version 2019 [<xref rid="pone.0274276.ref023" ref-type="bibr">23</xref>]. This coding system was selected because it is applied by at least 120 countries across the globe [<xref rid="pone.0274276.ref024" ref-type="bibr">24</xref>]. Considering the countries that apply different coding systems, we used the explicit names of the health condition mentioned in the included studies included to match them to the closest ICD-10 codes.</p><p>Descriptive statistics of the extracted data was calculated. The overall number of populations was calculated with considering the potential overlap between the included datasets. This overlap assessment was contemplated based on similarity of source of data, time span of data within each included study, the targeted health condition and the inclusion and exclusion criteria of the participants. The quantitative results were calculated using Microsoft Excel.</p></sec><sec id="sec005"><title>Risk of bias and applicability assessment</title><p>The &#8216;Prediction model study Risk Of Bias Assessment Tool&#8217; (PROBAST) was used to assess the risk of bias and concerns about the applicability of the included studies [<xref rid="pone.0274276.ref025" ref-type="bibr">25</xref>]. The four domains of this tool, which are participants, predictors, outcome, and analysis were addressed. The overall judgement for the risk of bias evaluation and concern of applicability of the prediction models in PROBAST is &#8216;low,&#8217; &#8216;high,&#8217; or &#8216;unclear.&#8217; In cases when all domains were graded &#8216;low&#8217; risk of bias, assessment of &#8216;models developed without external validation&#8217; was downgraded to &#8216;high&#8217; risk of bias even if all the four domains were of low risk of bias, unless the model&#8217;s development was based on an exceptionally large sample size and included some form of internal validation. External validation was considered if the model was at least validated using a dataset from a later time point in the same data source (temporal external validation) or using a different dataset from inside or outside the source country (geographical or broad external validation, respectively) [<xref rid="pone.0274276.ref020" ref-type="bibr">20</xref>]. Results of risk of bias and concern of applicability assessments were presented in a color-coded graph.</p></sec></sec><sec sec-type="results" id="sec006"><title>Results</title><p>Our search strategy yielded 23,045 publications. After duplicate removal, 19,280 publication abstracts were screened, and 167 publications were eligible for full text screening. A total of 106 publications met our inclusion criteria (<xref rid="pone.0274276.g001" ref-type="fig">Fig 1</xref>). A list of the excluded studies with the justification of exclusion is presented (<xref rid="pone.0274276.s001" ref-type="supplementary-material">S1 Table</xref>). The results of the data extracted in this review are presented in the following subsections: geographical and chronological characteristics of the included studies, studies&#8217; type and design, and the ML models addressed, and (frequency of) health conditions investigated.</p><fig position="float" id="pone.0274276.g001" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0274276.g001</object-id><label>Fig 1</label><caption><title>Prisma flow diagram.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0274276.g001.jpg"/></fig><sec id="sec007"><title>Geographical and chronological characteristics</title><p>The earliest included study was published in 2002 [<xref rid="pone.0274276.ref026" ref-type="bibr">26</xref>], with the most publications occurring over the past four years. Most (77.3%, n = 82/106) of the publications were published between 2018&#8211;2021 (<xref rid="pone.0274276.g002" ref-type="fig">Fig 2</xref>). The United States of America (US) and the United Kingdom (UK) were reported in 57.1% of the included publications. While the 106 included publications reported countries 126 times, the US was reported 41 times and the UK 31 times. Usage of exclusive real-world PHC data for modelling was reported in 77.7% (n = 115 of 148 counts of data sources) across the studies. The remaining 22.3% of the PHC data sources were linked to different data sources, such as health insurance claims, cancer registries, secondary or tertiary health care, or administrative data. In the US, data were obtained mainly from PHC centers. In contrast, the most common source of the UK data were the Clinical Practice Research Datalink (CPRD), which is the largest patients&#8217; data registry in the UK [<xref rid="pone.0274276.ref027" ref-type="bibr">27</xref>]. The overall time span of health data across the studies ranged from 1982 [<xref rid="pone.0274276.ref028" ref-type="bibr">28</xref>] to 2020 [<xref rid="pone.0274276.ref029" ref-type="bibr">29</xref>]. The individual time span of the included studies varied between 2 months to 28 years. Sample sizes across the included studies ranged from 75 [<xref rid="pone.0274276.ref030" ref-type="bibr">30</xref>] to around 4 million [<xref rid="pone.0274276.ref031" ref-type="bibr">31</xref>] participants. The total number of the populations within all the included studies was of 23.2 million. After correcting the potential overlaps, the total number of unique populations was reduced to be 22.7 million.</p><fig position="float" id="pone.0274276.g002" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0274276.g002</object-id><label>Fig 2</label><caption><title>Number of studies for publication years.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0274276.g002.jpg"/></fig></sec><sec id="sec008"><title>Studies type and design, and ML models</title><p>The main type of the included studies was prediction models development without external validations (76.5%, n = 81 of 106). Of the remaining 25 studies, 13 studies (12.2%) developed and externally validated the models, and 12 studies (10.3%) externally validated previously existing models. Temporal validation [<xref rid="pone.0274276.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0274276.ref032" ref-type="bibr">32</xref>&#8211;<xref rid="pone.0274276.ref036" ref-type="bibr">36</xref>], geographical validation [<xref rid="pone.0274276.ref037" ref-type="bibr">37</xref>, <xref rid="pone.0274276.ref038" ref-type="bibr">38</xref>], and using different population sample validations [<xref rid="pone.0274276.ref039" ref-type="bibr">39</xref>&#8211;<xref rid="pone.0274276.ref044" ref-type="bibr">44</xref>] were reported but none of these studies reported updating the assessed model.</p><p>All of the included studies were observational in design. Apart from 8 prospective studies, 92.4% (n = 98 of 106) of the studies were retrospective in design. Of the retrospective studies, 63 were retrospective cohorts. The other reported study designs were case control (n = 29), nested case control (n = 3), and cross sectional (n = 3). The purpose of the models reported was diagnostic in 77.3% (n = 82 of 106) of the studies, either incident (n = 62 of 82) or prevalent (n = 20 of 82). The remaining 23.5% (n = 25 of 106), including one study with two purposes of the models [<xref rid="pone.0274276.ref045" ref-type="bibr">45</xref>]) predicted prognosis of health conditions, such as remission, improvement, complications, hospitalization, or mortality. Despite all studies included used real-world patients&#8217; data to develop and/or validate the ML models, four studies reported applying the models develop in real-world primary health care settings [<xref rid="pone.0274276.ref046" ref-type="bibr">46</xref>&#8211;<xref rid="pone.0274276.ref048" ref-type="bibr">48</xref>].</p><p>Within the 106 included publications, 207 models were developed and/or validated. The most frequently used type of ML was supervised learning 83.1% (n = 172 of 207 models across the included studies). These supervised ML models were identified as follows: random forest (n = 58), SVM (n = 30), boosting models such as extreme, light, and adaptive boosting (n = 28), decision tree (n = 25), and others such as na&#239;ve bias, k-nearest neighbors, and LASSO (n = 31). Deep learning techniques, such as neural networks, were reported 35 times (16.9%, of 207models), either exclusively or in comparison to other supervised ML models. Supplementary table (<xref rid="pone.0274276.s002" ref-type="supplementary-material">S2 Table</xref>) presents advantages and disadvantages of these models in addition to further descriptive results of our included studies. The most frequently reported evaluation approach of models&#8217; performance was the area under the receiver operating characteristic curve (AUROC), which was reported as &#8220;good&#8221; to &#8220;moderate&#8221; models performance in 62 studies. One study reported the performance measures using decision analysis curve [<xref rid="pone.0274276.ref049" ref-type="bibr">49</xref>]. Other evaluation approaches were reported across the included studies, such as calculating sensitivity, specificity, predictive values, and accuracy.</p><p>The data used to develop the models were called predictors, features, or variables across the included studies. These data were mostly textual. Demographic characteristics and clinical picture of the health conditions were the most frequently found data. Medications, comorbidities, and blood tests performed within primary care unit were reported. Data, such as blood test results and imaging results performed within secondary and tertiary health care were additionally reported in some of the individual studies. Referral documentation and clinical notes taken by health care personnel were also reported. Five studies used the natural language processing (NLP) technique to handle free text clinical notes [<xref rid="pone.0274276.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0274276.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0274276.ref050" ref-type="bibr">50</xref>&#8211;<xref rid="pone.0274276.ref052" ref-type="bibr">52</xref>].</p><p>Tables <xref rid="pone.0274276.t002" ref-type="table">2</xref>&#8211;<xref rid="pone.0274276.t004" ref-type="table">4</xref> present an overview of the included studies characteristics based on the type of the study. They are grouped according to the ICD-10 classification and ordered alphabetically within each classification. A quantitative panel summary of all the included studies is also provided (<xref rid="pone.0274276.s005" ref-type="supplementary-material">S1 Panel</xref>).</p><table-wrap position="float" id="pone.0274276.t002" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0274276.t002</object-id><label>Table 2</label><caption><title>Overview of the included studies with the type of ML prediction models development without conducting external validation (n = 81).</title></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0274276.t002g" position="float" orientation="portrait" xlink:href="pone.0274276.t002.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Study</th><th align="center" rowspan="1" colspan="1">Study design</th><th align="center" rowspan="1" colspan="1">Models purpose</th><th align="center" rowspan="1" colspan="1">Country</th><th align="center" rowspan="1" colspan="1">Source of data</th><th align="center" rowspan="1" colspan="1">Sample size</th><th align="center" rowspan="1" colspan="1">Time span of data</th><th align="center" rowspan="1" colspan="1">Health condition</th></tr></thead><tbody><tr><td align="left" colspan="8" rowspan="1">
<bold>Circulatory System Diseases</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Chen <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref053" ref-type="bibr">53</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. nested case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">34,502</td><td align="left" rowspan="1" colspan="1">05/2000-05/2013</td><td align="left" rowspan="1" colspan="1">Heart failure</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Choi <italic toggle="yes">et al</italic>. 2017</bold> [<xref rid="pone.0274276.ref054" ref-type="bibr">54</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">32,787</td><td align="left" rowspan="1" colspan="1">05/2000-05/2013</td><td align="left" rowspan="1" colspan="1">Heart failure</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Du <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref055" ref-type="bibr">55</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">China</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">42,676</td><td align="left" rowspan="1" colspan="1">2010&#8211;2018</td><td align="left" rowspan="1" colspan="1">Hypertension</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Farran <italic toggle="yes">et al</italic>. 2013</bold> [<xref rid="pone.0274276.ref056" ref-type="bibr">56</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Kuwait</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">270,172</td><td align="left" rowspan="1" colspan="1">12 years</td><td align="left" rowspan="1" colspan="1">Any cardiovascular disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Hill <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref057" ref-type="bibr">57</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">2,994,837</td><td align="left" rowspan="1" colspan="1">01/2006-12/2016</td><td align="left" rowspan="1" colspan="1">Atrial fibrillation</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Karapetyan <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref029" ref-type="bibr">29</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">Germany</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">46,071</td><td align="left" rowspan="1" colspan="1">02-2020-09/2020</td><td align="left" rowspan="1" colspan="1">Any cardiovascular disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Lafreniere <italic toggle="yes">et al</italic>. 2017</bold> [<xref rid="pone.0274276.ref058" ref-type="bibr">58</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">379,027</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Hypertension</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Li <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref059" ref-type="bibr">59</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">3,661,932</td><td align="left" rowspan="1" colspan="1">01/1998-12/2018</td><td align="left" rowspan="1" colspan="1">Any cardiovascular disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Lip <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref060" ref-type="bibr">60</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">Australia</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">926</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Hypertension</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Lorenzoni <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref061" ref-type="bibr">61</xref>]</td><td align="left" rowspan="1" colspan="1">Pros. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">Italy</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">380</td><td align="left" rowspan="1" colspan="1">2011&#8211;2015</td><td align="left" rowspan="1" colspan="1">Heart failure</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ng <italic toggle="yes">et al</italic>. 2016</bold> [<xref rid="pone.0274276.ref062" ref-type="bibr">62</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. nested case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">152,095</td><td align="left" rowspan="1" colspan="1">2003&#8211;2010</td><td align="left" rowspan="1" colspan="1">Heart failure</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Nikolaou <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref063" ref-type="bibr">63</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">6,883</td><td align="left" rowspan="1" colspan="1">2015&#8211;2019</td><td align="left" rowspan="1" colspan="1">Any cardiovascular disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Sarraju <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref064" ref-type="bibr">64</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">32,192</td><td align="left" rowspan="1" colspan="1">01/2009-12/2018</td><td align="left" rowspan="1" colspan="1">Any cardiovascular disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Selskyy <italic toggle="yes">et al</italic>. 2018</bold> [<xref rid="pone.0274276.ref065" ref-type="bibr">65</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">Ukraine</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">2011&#8211;2012</td><td align="left" rowspan="1" colspan="1">Hypertension</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Shah <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref045" ref-type="bibr">45</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic/Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">2,000</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Myocardial infarction</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Solanki <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref066" ref-type="bibr">66</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">495</td><td align="left" rowspan="1" colspan="1">2007&#8211;2017</td><td align="left" rowspan="1" colspan="1">Hypertension</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Solares <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref067" ref-type="bibr">67</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">80,964</td><td align="left" rowspan="1" colspan="1">entry&#8211; 01/2014</td><td align="left" rowspan="1" colspan="1">Any cardiovascular disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ward <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref068" ref-type="bibr">68</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">262,923</td><td align="left" rowspan="1" colspan="1">01/2009-12/2018</td><td align="left" rowspan="1" colspan="1">Atherosclerosis</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Weng <italic toggle="yes">et al</italic>. 2017</bold> [<xref rid="pone.0274276.ref069" ref-type="bibr">69</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">378,256</td><td align="left" rowspan="1" colspan="1">01/2005-01/2015</td><td align="left" rowspan="1" colspan="1">Any cardiovascular disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Wu <italic toggle="yes">et al</italic>. 2010</bold> [<xref rid="pone.0274276.ref070" ref-type="bibr">70</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">44,895</td><td align="left" rowspan="1" colspan="1">01/2003-12/2006</td><td align="left" rowspan="1" colspan="1">Heart failure</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Zhao <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref040" ref-type="bibr">40</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">4,914</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Stroke</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Digestive System Diseases</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>S&#225;enz Bajo <italic toggle="yes">et al</italic>. 2002</bold> [<xref rid="pone.0274276.ref026" ref-type="bibr">26</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">Spain</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">81</td><td align="left" rowspan="1" colspan="1">01/1999-06/1999</td><td align="left" rowspan="1" colspan="1">Gastroesophageal reflux</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Waljee <italic toggle="yes">et al</italic>. 2018</bold> [<xref rid="pone.0274276.ref071" ref-type="bibr">71</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">20,368</td><td align="left" rowspan="1" colspan="1">2002&#8211;2009</td><td align="left" rowspan="1" colspan="1">Inflammatory bowel disorders</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Endocrine, Metabolic, and Nutritional Diseases</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Akyea <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref031" ref-type="bibr">31</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">4,027,775</td><td align="left" rowspan="1" colspan="1">01/1999-06/2019</td><td align="left" rowspan="1" colspan="1">Familial hypercholesterolemia</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>&#193;-Guisasola <italic toggle="yes">et al</italic>. 2010</bold> [<xref rid="pone.0274276.ref072" ref-type="bibr">72</xref>]</td><td align="left" rowspan="1" colspan="1">Pros. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Spain</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">2,662</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Diabetes mellitus</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Crutzen <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref073" ref-type="bibr">73</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">The Netherlands</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">138,767</td><td align="left" rowspan="1" colspan="1">01/2007-01/2014</td><td align="left" rowspan="1" colspan="1">Diabetes mellitus</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ding <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref074" ref-type="bibr">74</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">97,584</td><td align="left" rowspan="1" colspan="1">1997&#8211;2017</td><td align="left" rowspan="1" colspan="1">Primary Aldosteronism</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Dugan <italic toggle="yes">et al</italic>. 2015</bold> [<xref rid="pone.0274276.ref075" ref-type="bibr">75</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">7,519</td><td align="left" rowspan="1" colspan="1">Over 9 years</td><td align="left" rowspan="1" colspan="1">Obesity</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Farran <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref076" ref-type="bibr">76</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">Kuwait</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">1,837</td><td align="left" rowspan="1" colspan="1">Over 9 years</td><td align="left" rowspan="1" colspan="1">Diabetes mellitus</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Hammond <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref077" ref-type="bibr">77</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">3,449</td><td align="left" rowspan="1" colspan="1">01/2008-08/2016</td><td align="left" rowspan="1" colspan="1">Obesity</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kopitar <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref078" ref-type="bibr">78</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Slovenia</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">27,050</td><td align="left" rowspan="1" colspan="1">12/2014-09/2017</td><td align="left" rowspan="1" colspan="1">Diabetes mellitus</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Lethebe <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref079" ref-type="bibr">79</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">1,309</td><td align="left" rowspan="1" colspan="1">2008&#8211;2016</td><td align="left" rowspan="1" colspan="1">Diabetes mellitus</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Looker <italic toggle="yes">et al</italic>. 2015</bold> [<xref rid="pone.0274276.ref080" ref-type="bibr">80</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">309</td><td align="left" rowspan="1" colspan="1">12/1998-05/2009</td><td align="left" rowspan="1" colspan="1">Diabetic nephropathy</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Metsker <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref081" ref-type="bibr">81</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Russia</td><td align="left" rowspan="1" colspan="1">NR</td><td align="right" rowspan="1" colspan="1">54,252</td><td align="left" rowspan="1" colspan="1">07/2009-08/2017</td><td align="left" rowspan="1" colspan="1">Diabetic polyneuropathy</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Metzker <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref082" ref-type="bibr">82</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Russia</td><td align="left" rowspan="1" colspan="1">NR</td><td align="right" rowspan="1" colspan="1">58,462</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Diabetic polyneuropathy</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Nagaraj <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref083" ref-type="bibr">83</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">The Netherlands</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">11,887</td><td align="left" rowspan="1" colspan="1">01/2007-12/2013</td><td align="left" rowspan="1" colspan="1">Diabetes mellitus</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Pakhomov <italic toggle="yes">et al</italic>. 2008</bold> [<xref rid="pone.0274276.ref050" ref-type="bibr">50</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">145</td><td align="left" rowspan="1" colspan="1">07/2004-09/2004</td><td align="left" rowspan="1" colspan="1">Diabetic foot</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Rumora <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref084" ref-type="bibr">84</xref>]</td><td align="left" rowspan="1" colspan="1">Cross sectional</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Denmark</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">97</td><td align="left" rowspan="1" colspan="1">10/2015-06/2016</td><td align="left" rowspan="1" colspan="1">Diabetic polyneuropathy</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Tseng <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref052" ref-type="bibr">52</xref>]</td><td align="left" rowspan="1" colspan="1">Cross sectional</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">NR</td><td align="left" rowspan="1" colspan="1">07/2016-12/2018</td><td align="left" rowspan="1" colspan="1">Diabetes mellitus</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Wang <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref085" ref-type="bibr">85</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">China</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">1,139</td><td align="left" rowspan="1" colspan="1">2017&#8211;2019</td><td align="left" rowspan="1" colspan="1">Gestational diabetes</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Williamson <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref086" ref-type="bibr">86</xref>]</td><td align="left" rowspan="1" colspan="1">Pros. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">866</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Familial hypercholesterolemia</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>External Cause of Mortality</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>DelPozo-Banos <italic toggle="yes">et al</italic>. 2018</bold> [<xref rid="pone.0274276.ref087" ref-type="bibr">87</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">54,684</td><td align="left" rowspan="1" colspan="1">2001&#8211;2015</td><td align="left" rowspan="1" colspan="1">Suicidality</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Penfold <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref088" ref-type="bibr">88</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">256,823</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Suicidality</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>van Mens <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref089" ref-type="bibr">89</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">The Netherlands</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">207,882</td><td align="left" rowspan="1" colspan="1">2017</td><td align="left" rowspan="1" colspan="1">Suicidality</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Genitourinary System Diseases</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Shih <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref090" ref-type="bibr">90</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Taiwan</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">19,270</td><td align="left" rowspan="1" colspan="1">01/2015-12/2019</td><td align="left" rowspan="1" colspan="1">Chronic kidney disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Zhao <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref091" ref-type="bibr">91</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">61,740</td><td align="left" rowspan="1" colspan="1">2009&#8211;2017</td><td align="left" rowspan="1" colspan="1">Chronic kidney disease</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Mental and Behavioral Diseases</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Dinga <italic toggle="yes">et al</italic>. 2018</bold> [<xref rid="pone.0274276.ref092" ref-type="bibr">92</xref>]</td><td align="left" rowspan="1" colspan="1">Pros. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">The Netherlands</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">804</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Depression</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ford <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref093" ref-type="bibr">93</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">93,120</td><td align="left" rowspan="1" colspan="1">2000&#8211;2012</td><td align="left" rowspan="1" colspan="1">Alzheimer&#8217;s disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ford <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref094" ref-type="bibr">94</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">95,202</td><td align="left" rowspan="1" colspan="1">2000&#8211;2012</td><td align="left" rowspan="1" colspan="1">Alzheimer&#8217;s disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ford <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref095" ref-type="bibr">95</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">93,426</td><td align="left" rowspan="1" colspan="1">2000&#8211;2012</td><td align="left" rowspan="1" colspan="1">Alzheimer&#8217;s disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Fouladvand <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref096" ref-type="bibr">96</xref><bold>]</bold></td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">3,265</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Alzheimer&#8217;s disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Haun <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref097" ref-type="bibr">97</xref>]</td><td align="left" rowspan="1" colspan="1">Cross sectional</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Germany</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">496</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Anxiety</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Jammeh <italic toggle="yes">et al</italic>. 2018</bold> [<xref rid="pone.0274276.ref098" ref-type="bibr">98</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">3,063</td><td align="left" rowspan="1" colspan="1">06/2010-06/2012</td><td align="left" rowspan="1" colspan="1">Alzheimer&#8217;s disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Jin <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref099" ref-type="bibr">99</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">923</td><td align="left" rowspan="1" colspan="1">2010&#8211;2013</td><td align="left" rowspan="1" colspan="1">Depression</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kaczmarek <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref100" ref-type="bibr">100</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">890</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Post-traumatic stress disorder</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ljubic <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref101" ref-type="bibr">101</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">2,324</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Alzheimer&#8217;s disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Mallo <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref102" ref-type="bibr">102</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">Spain</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">128</td><td align="left" rowspan="1" colspan="1">2008</td><td align="left" rowspan="1" colspan="1">Alzheimer&#8217;s disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Mar <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref103" ref-type="bibr">103</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">Spain</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">4,003</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Alzheimer&#8217;s disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>P&#243;&#322;ch&#322;opek <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref104" ref-type="bibr">104</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">The Netherlands</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">92,621</td><td align="left" rowspan="1" colspan="1">2007-12/2016</td><td align="left" rowspan="1" colspan="1">Any mental disorder</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Shen <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref105" ref-type="bibr">105</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">China</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">2,299</td><td align="left" rowspan="1" colspan="1">2008&#8211;2018</td><td align="left" rowspan="1" colspan="1">Alzheimer&#8217;s disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Su&#225;rez-Araujo <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref106" ref-type="bibr">106</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">330</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Alzheimer&#8217;s disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Tsang <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref028" ref-type="bibr">28</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">59,298</td><td align="left" rowspan="1" colspan="1">1982&#8211;2015</td><td align="left" rowspan="1" colspan="1">Alzheimer&#8217;s disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Zafari <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref107" ref-type="bibr">107</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">154,118</td><td align="left" rowspan="1" colspan="1">01/1995-12/2017</td><td align="left" rowspan="1" colspan="1">Post-traumatic stress disorder</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Musculoskeletal and Connective Tissue Diseases</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Emir <italic toggle="yes">et al</italic>. 2014</bold> [<xref rid="pone.0274276.ref108" ref-type="bibr">108</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">587,961</td><td align="left" rowspan="1" colspan="1">2011&#8211;2012</td><td align="left" rowspan="1" colspan="1">Fibromyalgia</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Jarvik <italic toggle="yes">et al</italic>. 2018</bold> [<xref rid="pone.0274276.ref109" ref-type="bibr">109</xref>]</td><td align="left" rowspan="1" colspan="1">Pros. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">3,971</td><td align="left" rowspan="1" colspan="1">03/2011-03/2013</td><td align="left" rowspan="1" colspan="1">Back pain</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kennedy <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref110" ref-type="bibr">110</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">23,528</td><td align="left" rowspan="1" colspan="1">Over 6 years</td><td align="left" rowspan="1" colspan="1">Ankylosing spondylitis</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Neoplasms</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kop <italic toggle="yes">et al</italic>. 2016</bold> [<xref rid="pone.0274276.ref111" ref-type="bibr">111</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">The Netherlands</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">260,000</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Colorectal cancer</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Malhotra <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref112" ref-type="bibr">112</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">5,695</td><td align="left" rowspan="1" colspan="1">01/2005-06/2009</td><td align="left" rowspan="1" colspan="1">Pancreatic cancer</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ristanoski <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref113" ref-type="bibr">113</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Australia</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">683</td><td align="left" rowspan="1" colspan="1">2016&#8211;2017</td><td align="left" rowspan="1" colspan="1">Lung cancer</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Nervous System Diseases</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Cox <italic toggle="yes">et al</italic>. 2016</bold> [<xref rid="pone.0274276.ref114" ref-type="bibr">114</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">3,960</td><td align="left" rowspan="1" colspan="1">01/2007-12/2011</td><td align="left" rowspan="1" colspan="1">Post stroke spasticity</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Hrabok <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref115" ref-type="bibr">115</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">10,499</td><td align="left" rowspan="1" colspan="1">01/2000-05/2012</td><td align="left" rowspan="1" colspan="1">Epilepsy</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kwasny <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref116" ref-type="bibr">116</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Germany</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">3,274</td><td align="left" rowspan="1" colspan="1">01/2010-12/2017</td><td align="left" rowspan="1" colspan="1">Progressive supranuclear palsy</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Respiratory System Diseases</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Afzal <italic toggle="yes">et al</italic>. 2013</bold> [<xref rid="pone.0274276.ref117" ref-type="bibr">117</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">The Netherlands</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">5,032</td><td align="left" rowspan="1" colspan="1">01/2000-01/2012</td><td align="left" rowspan="1" colspan="1">Asthma</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Doyle <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref118" ref-type="bibr">118</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">112,784</td><td align="left" rowspan="1" colspan="1">09/2003-09/2017</td><td align="left" rowspan="1" colspan="1">Non-tuberculous mycobacterial lung</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kaplan <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref032" ref-type="bibr">32</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">411,563</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Asthma/obstructive pulmonary disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Lisspers <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref041" ref-type="bibr">41</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">Sweden</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">29,396</td><td align="left" rowspan="1" colspan="1">01/2000-12/2013</td><td align="left" rowspan="1" colspan="1">Asthma</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Marin-Gomez <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref042" ref-type="bibr">42</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Spain</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">7,314</td><td align="left" rowspan="1" colspan="1">03/04/2020</td><td align="left" rowspan="1" colspan="1">COVID-19</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>St&#228;llberg <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref033" ref-type="bibr">33</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">Sweden</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">7,823</td><td align="left" rowspan="1" colspan="1">01/2000-12/2013</td><td align="left" rowspan="1" colspan="1">Chronic obstructive pulmonary disease</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Stephens <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref051" ref-type="bibr">51</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">7,278</td><td align="left" rowspan="1" colspan="1">2009&#8211;2019</td><td align="left" rowspan="1" colspan="1">Influenza</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Trtica-Majnaric <italic toggle="yes">et al</italic>. 2010</bold> [<xref rid="pone.0274276.ref043" ref-type="bibr">43</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">Croatia</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">90</td><td align="left" rowspan="1" colspan="1">2003&#8211;2004</td><td align="left" rowspan="1" colspan="1">Influenza</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Zafari <italic toggle="yes">et al</italic>. 2022</bold> [<xref rid="pone.0274276.ref044" ref-type="bibr">44</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">4,134</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">Chronic obstructive pulmonary disease</td></tr></tbody></table></alternatives></table-wrap><table-wrap position="float" id="pone.0274276.t003" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0274276.t003</object-id><label>Table 3</label><caption><title>Overview of the included studies with the type of ML prediction models development with conduction of external validation (n = 13).</title></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0274276.t003g" position="float" orientation="portrait" xlink:href="pone.0274276.t003.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Study</th><th align="center" rowspan="1" colspan="1">Study design</th><th align="center" rowspan="1" colspan="1">Models purpose</th><th align="center" rowspan="1" colspan="1">Country</th><th align="center" rowspan="1" colspan="1">Source of data</th><th align="center" rowspan="1" colspan="1">Sample size</th><th align="center" rowspan="1" colspan="1">Time span of data</th><th align="center" rowspan="1" colspan="1">Health condition</th></tr></thead><tbody><tr><td align="left" colspan="8" rowspan="1">
<bold>Endocrine, Metabolic, and Nutritional Diseases</bold>
</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>Hertroijs <italic toggle="yes">et al</italic>. 2018</bold> [<xref rid="pone.0274276.ref049" ref-type="bibr">49</xref>]<xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="2" colspan="1">Retro. cohort</td><td align="left" rowspan="2" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">The Netherlands</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">10,528</td><td align="left" rowspan="1" colspan="1">01/2006-12/2014</td><td align="center" rowspan="2" colspan="1">Diabetes mellitus</td></tr><tr><td align="left" rowspan="1" colspan="1">The Netherlands</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">3,337</td><td align="left" rowspan="1" colspan="1">01/2009-12/2013</td></tr><tr><td align="left" rowspan="4" colspan="1"><bold>Myers <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref039" ref-type="bibr">39</xref>] <xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="4" colspan="1">Retro. case control</td><td align="left" rowspan="4" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">33,086</td><td align="left" rowspan="4" colspan="1">09/2013-08/2016</td><td align="center" rowspan="4" colspan="1">Familial hypercholesterolemia</td></tr><tr><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">7,805</td></tr><tr><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">35,090</td></tr><tr><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">8,094</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>Perveen <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref034" ref-type="bibr">34</xref>] <xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="2" colspan="1">Retro. cohort</td><td align="left" rowspan="2" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">911</td><td align="left" rowspan="2" colspan="1">08/2003-06/2015</td><td align="center" rowspan="2" colspan="1">Diabetes mellitus</td></tr><tr><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">1,970</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>Weisman <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref119" ref-type="bibr">119</xref>] <xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="2" colspan="1">Retro. cohort</td><td align="left" rowspan="2" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">5,402</td><td align="left" rowspan="2" colspan="1">2010&#8211;2017</td><td align="center" rowspan="2" colspan="1">Diabetes mellitus</td></tr><tr><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">29,371</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Mental and Behavioral Diseases</bold>
</td></tr><tr><td align="left" rowspan="3" colspan="1"><bold>Amit <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref120" ref-type="bibr">120</xref>] <xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="3" colspan="1">Retro. cohort</td><td align="left" rowspan="3" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">24,612</td><td align="left" rowspan="1" colspan="1">2000&#8211;2010</td><td align="left" rowspan="3" colspan="1">Post-partum depression</td></tr><tr><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">9,193</td><td align="left" rowspan="1" colspan="1">2010&#8211;2017</td></tr><tr><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">34,525</td><td align="left" rowspan="1" colspan="1">2000&#8211;2017</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>Levy <italic toggle="yes">et al</italic>. 2018</bold> [<xref rid="pone.0274276.ref030" ref-type="bibr">30</xref>] <xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="2" colspan="1">Retro. cohort</td><td align="left" rowspan="2" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">Over 9 months</td><td align="left" rowspan="2" colspan="1">Alzheimer&#8217;s disease</td></tr><tr><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">Not reported</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>Perlis 2013</bold> [<xref rid="pone.0274276.ref121" ref-type="bibr">121</xref>] <xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="2" colspan="1">Retro. cohort</td><td align="left" rowspan="2" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">2,094</td><td align="left" rowspan="2" colspan="1">1999&#8211;2006</td><td align="left" rowspan="2" colspan="1">Depression</td></tr><tr><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">461</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>Raket <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref035" ref-type="bibr">35</xref>] <xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="2" colspan="1">Retro. case control</td><td align="left" rowspan="2" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">145,720</td><td align="left" rowspan="2" colspan="1">1990&#8211;2018</td><td align="left" rowspan="2" colspan="1">Psychosis</td></tr><tr><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">4,770</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Musculoskeletal and Connective Tissue Diseases</bold>
</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>Fernandez-Gutierrez <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref122" ref-type="bibr">122</xref>] <xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="2" colspan="1">Retro. cohort</td><td align="left" rowspan="2" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">19,314</td><td align="left" rowspan="2" colspan="1">2002&#8211;2012</td><td align="left" rowspan="2" colspan="1">Rheumatoid arthritis &amp; Ankylosing spondylitis</td></tr><tr><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">1,868</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>Jorge <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref123" ref-type="bibr">123</xref>] <xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="2" colspan="1">Retro. cohort</td><td align="left" rowspan="2" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">400</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="2" colspan="1">Systematic lupus erythematous</td></tr><tr><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">173</td><td align="left" rowspan="1" colspan="1">Not reported</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>Zhou <italic toggle="yes">et al</italic>. 2017</bold> [<xref rid="pone.0274276.ref124" ref-type="bibr">124</xref>] <xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="2" colspan="1">Retro. cohort</td><td align="left" rowspan="2" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">10/2013-07/2014</td><td align="left" rowspan="2" colspan="1">Rheumatoid arthritis</td></tr><tr><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">475,580</td><td align="left" rowspan="1" colspan="1">03/2009-10/2012</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Neoplasms</bold>
</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>Kinar <italic toggle="yes">et al</italic>. 2016</bold> [<xref rid="pone.0274276.ref125" ref-type="bibr">125</xref>] <xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="2" colspan="1">Retro. cohort</td><td align="left" rowspan="2" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Israel</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">606,403</td><td align="left" rowspan="1" colspan="1">01/2003-07/2011</td><td align="left" rowspan="2" colspan="1">Colorectal cancer</td></tr><tr><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">30,674</td><td align="left" rowspan="1" colspan="1">01/2003-05/2012</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Pregnancy, Childbirth, Puerperium</bold>
</td></tr><tr><td align="left" rowspan="3" colspan="1"><bold>Sufriyana <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref126" ref-type="bibr">126</xref>] <xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="3" colspan="1">Retro. nested case control</td><td align="left" rowspan="3" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Indonesia</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">20,975</td><td align="left" rowspan="1" colspan="1">2015&#8211;2016</td><td align="center" rowspan="3" colspan="1">Preeclampsia</td></tr><tr><td align="left" rowspan="1" colspan="1">Indonesia</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">1,322</td><td align="left" rowspan="1" colspan="1">Not reported</td></tr><tr><td align="left" rowspan="1" colspan="1">Indonesia</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">904</td><td align="left" rowspan="1" colspan="1">Not reported</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p><sup>a</sup>Each row per study represents a different dataset that was used to develop and/or validate the prediction models.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pone.0274276.t004" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0274276.t004</object-id><label>Table 4</label><caption><title>Overview of the included studies with the type of reporting external validation of previously developed ML prediction models (n = 12).</title></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0274276.t004g" position="float" orientation="portrait" xlink:href="pone.0274276.t004.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Study</th><th align="center" rowspan="1" colspan="1">Study design</th><th align="center" rowspan="1" colspan="1">Models purpose</th><th align="center" rowspan="1" colspan="1">Country</th><th align="center" rowspan="1" colspan="1">Source of data</th><th align="center" rowspan="1" colspan="1">Sample size</th><th align="center" rowspan="1" colspan="1">Time span of data</th><th align="center" rowspan="1" colspan="1">Health condition</th></tr></thead><tbody><tr><td align="left" colspan="8" rowspan="1">
<bold>Circulatory System Diseases</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kostev <italic toggle="yes">et al</italic>. 2021</bold> [<xref rid="pone.0274276.ref037" ref-type="bibr">37</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Germany</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">11,466</td><td align="left" rowspan="1" colspan="1">01/2010-12/2018</td><td align="left" rowspan="1" colspan="1">Stroke</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Sekelj <italic toggle="yes">et al</italic>. 2020</bold> [<xref rid="pone.0274276.ref036" ref-type="bibr">36</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">604,135</td><td align="left" rowspan="1" colspan="1">01/2001-12/2016</td><td align="left" rowspan="1" colspan="1">Atrial fibrillation</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Endocrine, Metabolic, and Nutritional Diseases</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Abramoff <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref127" ref-type="bibr">127</xref>]</td><td align="left" rowspan="1" colspan="1">Pros. cohort</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">819</td><td align="left" rowspan="1" colspan="1">01/2017-07/2017</td><td align="left" rowspan="1" colspan="1">Diabetic retinopathy</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Bhaskaranand <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref128" ref-type="bibr">128</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">1,017,001</td><td align="left" rowspan="1" colspan="1">01/2014-09/2015</td><td align="left" rowspan="1" colspan="1">Diabetic retinopathy</td></tr><tr><td align="left" rowspan="5" colspan="1"><bold>Gonz&#225;lez-Gonzalo <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref129" ref-type="bibr">129</xref>] <xref rid="t004fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="5" colspan="1">Retro. case control</td><td align="left" rowspan="5" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">Spain</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="3" colspan="1">288</td><td align="left" rowspan="3" colspan="1">08/2011-10/2016</td><td align="left" rowspan="5" colspan="1">Diabetic retinopathy</td></tr><tr><td align="left" rowspan="1" colspan="1">Sweden</td><td align="left" rowspan="1" colspan="1">PHC</td></tr><tr><td align="left" rowspan="1" colspan="1">Denmark</td><td align="left" rowspan="1" colspan="1">PHC</td></tr><tr><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="2" colspan="1">4,613</td><td align="left" rowspan="2" colspan="1">Over 2014</td></tr><tr><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">Linked data</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kanagasingam <italic toggle="yes">et al</italic>. 2018</bold> [<xref rid="pone.0274276.ref130" ref-type="bibr">130</xref>]</td><td align="left" rowspan="1" colspan="1">Pros. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Australia</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">193</td><td align="left" rowspan="1" colspan="1">12.2016-05/2017</td><td align="left" rowspan="1" colspan="1">Diabetic retinopathy</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Verbraak <italic toggle="yes">et al</italic>. 2019</bold> [<xref rid="pone.0274276.ref046" ref-type="bibr">46</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">The Netherlands</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">1,425</td><td align="left" rowspan="1" colspan="1">2015</td><td align="left" rowspan="1" colspan="1">Diabetic retinopathy</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Neoplasms</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Birks <italic toggle="yes">et al</italic>. 2017</bold> [<xref rid="pone.0274276.ref038" ref-type="bibr">38</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">2,550,119</td><td align="left" rowspan="1" colspan="1">01/2000-04/2015</td><td align="left" rowspan="1" colspan="1">Colorectal cancer</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Hoogendoorn <italic toggle="yes">et al</italic>. 2016</bold> [<xref rid="pone.0274276.ref131" ref-type="bibr">131</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Prevalent diagnostic</td><td align="left" rowspan="1" colspan="1">The Netherlands</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">90,000</td><td align="left" rowspan="1" colspan="1">07/2006-12/2011</td><td align="left" rowspan="1" colspan="1">Colorectal cancer</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Hornbrook <italic toggle="yes">et al</italic>. 2017</bold> [<xref rid="pone.0274276.ref047" ref-type="bibr">47</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. case control</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">United States</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">17,095</td><td align="left" rowspan="1" colspan="1">1998&#8211;2013</td><td align="left" rowspan="1" colspan="1">Colorectal cancer</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kinar <italic toggle="yes">et al</italic>. 2017</bold> [<xref rid="pone.0274276.ref048" ref-type="bibr">48</xref>]</td><td align="left" rowspan="1" colspan="1">Pros. cohort</td><td align="left" rowspan="1" colspan="1">Incident diagnostic</td><td align="left" rowspan="1" colspan="1">Israel</td><td align="left" rowspan="1" colspan="1">Linked data</td><td align="right" rowspan="1" colspan="1">112,584</td><td align="left" rowspan="1" colspan="1">07/2007-12/2007</td><td align="left" rowspan="1" colspan="1">Colorectal cancer</td></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>Respiratory System Diseases</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Morales <italic toggle="yes">et al</italic>. 2018</bold> [<xref rid="pone.0274276.ref132" ref-type="bibr">132</xref>]</td><td align="left" rowspan="1" colspan="1">Retro. cohort</td><td align="left" rowspan="1" colspan="1">Prognostic</td><td align="left" rowspan="1" colspan="1">United Kingdom</td><td align="left" rowspan="1" colspan="1">PHC</td><td align="right" rowspan="1" colspan="1">2,044,733</td><td align="left" rowspan="1" colspan="1">01/2000-04/2014</td><td align="left" rowspan="1" colspan="1">Chronic obstructive pulmonary disease</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p><sup>a</sup>Each row per study represents a different dataset that was used to develop and/or validate the prediction models.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec009"><title>Health conditions</title><p>Out of the 22 classifications of the ICD-10, 11 classifications were addressed in the included studies. Frequently reported classifications were the endocrine, nutritional, and metabolic diseases classification (ICD-10: Class E00-E90) (n = 27 studies of 106, 25.5%), circulatory system diseases (ICD-10: Class I00-I99) (n = 23, 21.7%), and the mental and behavioral disorders classification (ICD-10: Class F00-F99) (n = 21, 19.9%). Diseases of the respiratory system classifications (ICD-10: Class J00-J99) and neoplasms (ICD-10: Class C00-C97) were addressed in (n = 10, 9.4% and n = 8, 7.5% respectively). 16% (n = 17) of the included studies investigated other health conditions (ICD 10: Classes G00-G99, K00-K93, M00-M99, N00-N99, O00-O99, and X60-X84).</p><sec id="sec010"><title>Endocrine, nutritional, and metabolic diseases (E00-E90)</title><p>In 27 studies addressing this classification [<xref rid="pone.0274276.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0274276.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0274276.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0274276.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0274276.ref049" ref-type="bibr">49</xref>, <xref rid="pone.0274276.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0274276.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0274276.ref072" ref-type="bibr">72</xref>&#8211;<xref rid="pone.0274276.ref086" ref-type="bibr">86</xref>, <xref rid="pone.0274276.ref119" ref-type="bibr">119</xref>, <xref rid="pone.0274276.ref127" ref-type="bibr">127</xref>&#8211;<xref rid="pone.0274276.ref130" ref-type="bibr">130</xref>], populations involved were from 12 countries, mainly the US (41.9%). The studies were published since 2008 with the highest number of studies in 2019 (38.7%). 81% of the included studies reported the development and/or training of the proposed models using exclusive primary health care data of a total number of 4.2 million participants. Data were extracted from different sources covering a time span of six months to 23 years. Four health conditions were identified, namely diabetes mellitus (E10, E11) with/without complications (n = 21), familial hypercholesterolemia (E78) (n = 3), childhood obesity (E66) (n = 2), and primary aldosteronism (E26) (n = 1). Incident diagnostic prediction was the most commonly reported outcome (42%). Prevalent diagnostic and prognostic prediction were 32% and 26% respectively. Diabetic retinopathy was the most common complication (n = 5 of 21 related diabetes mellitus studies) reported. Diabetic foot was investigated in one study [<xref rid="pone.0274276.ref050" ref-type="bibr">50</xref>]. Two studies investigated prognostic predictive modelling of the short- and long-term levels of HbA1c after insulin treatment [<xref rid="pone.0274276.ref049" ref-type="bibr">49</xref>, <xref rid="pone.0274276.ref083" ref-type="bibr">83</xref>].</p></sec><sec id="sec011"><title>Mental and behavioral disorder (F00&#8211;F99)</title><p>In 21 studies addressing six health conditions [<xref rid="pone.0274276.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0274276.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0274276.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0274276.ref092" ref-type="bibr">92</xref>&#8211;<xref rid="pone.0274276.ref107" ref-type="bibr">107</xref>, <xref rid="pone.0274276.ref120" ref-type="bibr">120</xref>, <xref rid="pone.0274276.ref121" ref-type="bibr">121</xref>, <xref rid="pone.0274276.ref133" ref-type="bibr">133</xref>], the populations were from eight countries, mainly the US and the UK (n = 13). These 21 studies were published since 2013 with the highest number published in 2020 (44.4%). Data were collected from different data sources with time span of data from one year to 28 years. Alzheimer&#8217;s disease (F00) was addressed in 12 studies for mostly incident or prevalent diagnosis, apart from three studies. Depression (F32) was tackled in three studies, one of which predicted depression prognosis within two years [<xref rid="pone.0274276.ref092" ref-type="bibr">92</xref>]. Psychosis (F29) [<xref rid="pone.0274276.ref035" ref-type="bibr">35</xref>] and anxiety (F41) in cancer survivors seeking care in PHC [<xref rid="pone.0274276.ref097" ref-type="bibr">97</xref>] were addressed in one study each. Lastly, one study used PHC data to predict any mental disorder using different ML models [<xref rid="pone.0274276.ref104" ref-type="bibr">104</xref>].</p></sec><sec id="sec012"><title>Circulatory and respiratory health conditions (I00-I99 and J00-J99)</title><p>In 33 studies, populations involved were from 11 countries, mainly the US and the UK. The included studies were published since 2010 with the highest number in both groups published in 2020 (30.8%). Data were extracted from the different data sources over time span one month to 23 years. Six circulatory health conditions were identified in 23 studies [<xref rid="pone.0274276.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0274276.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0274276.ref037" ref-type="bibr">37</xref>, <xref rid="pone.0274276.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0274276.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0274276.ref053" ref-type="bibr">53</xref>&#8211;<xref rid="pone.0274276.ref070" ref-type="bibr">70</xref>]. These conditions were hypertension (I10-I15) (n = 5), heart failure (I50) (n = 5), atrial fibrillation (I48) (n = 2), stroke (I64) (n = 2), atherosclerosis (I70) (n = 1), myocardial infarction (I21) (n = 1), and any cardiovascular event or disease (n = 7). Five respiratory health conditions were investigated in 10 studies [<xref rid="pone.0274276.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0274276.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0274276.ref041" ref-type="bibr">41</xref>&#8211;<xref rid="pone.0274276.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0274276.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0274276.ref117" ref-type="bibr">117</xref>, <xref rid="pone.0274276.ref118" ref-type="bibr">118</xref>, <xref rid="pone.0274276.ref132" ref-type="bibr">132</xref>, <xref rid="pone.0274276.ref134" ref-type="bibr">134</xref>, <xref rid="pone.0274276.ref135" ref-type="bibr">135</xref>]. Four studies predicted mortality and hospitalization risks on top of chronic obstructive pulmonary disease (COPD) (J40). Two studies investigated prevalent diagnosis of Asthma (J45) and its exacerbation risk. Influenza was predicated in two studies [<xref rid="pone.0274276.ref117" ref-type="bibr">117</xref>, <xref rid="pone.0274276.ref124" ref-type="bibr">124</xref>] for incident cases and prognosis. COVID-19 (U07) incident cases were predicted within routine PHC visits in one study [<xref rid="pone.0274276.ref042" ref-type="bibr">42</xref>].</p></sec><sec id="sec013"><title>Other health conditions</title><p>Eight studies colorectal cancer (CRC) (C18) (n = 6), lung cancer (C34) (n = 1), and pancreatic cancer (C25) (n = 1). Four studies addressed the same incidence prediction model known as ColonFlag (previously MeScore) to identify CRC cases [<xref rid="pone.0274276.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0274276.ref047" ref-type="bibr">47</xref>, <xref rid="pone.0274276.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0274276.ref125" ref-type="bibr">125</xref>]. Each study predicted incident cases within different time windows before diagnosis; from three months to two years. Three health conditions affecting the nervous system were addressed [<xref rid="pone.0274276.ref114" ref-type="bibr">114</xref>&#8211;<xref rid="pone.0274276.ref116" ref-type="bibr">116</xref>], which were post stroke spasticity, epilepsy specifically mortality four years before and after its diagnosis (G40) [<xref rid="pone.0274276.ref115" ref-type="bibr">115</xref>], and a rare neurodegenerative disease progressive supra-nuclear palsy (G23) [<xref rid="pone.0274276.ref116" ref-type="bibr">116</xref>]. A few studies investigated musculoskeletal and connective tissue disorders as well as gastrointestinal and kidney diseases [<xref rid="pone.0274276.ref122" ref-type="bibr">122</xref>&#8211;<xref rid="pone.0274276.ref124" ref-type="bibr">124</xref>, <xref rid="pone.0274276.ref108" ref-type="bibr">108</xref>&#8211;<xref rid="pone.0274276.ref110" ref-type="bibr">110</xref>]. The musculoskeletal and connective tissue condition were back pain (M54) prognosis within PHC settings [<xref rid="pone.0274276.ref109" ref-type="bibr">109</xref>], ankylosing spondylitis (M45) [<xref rid="pone.0274276.ref110" ref-type="bibr">110</xref>]. The gastrointestinal and kidney diseases were examined in four studies, namely inflammatory bowel diseases (K50-K52), including Crohn&#8217;s disease and ulcerative colitis [<xref rid="pone.0274276.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0274276.ref071" ref-type="bibr">71</xref>], peptic ulcers (K27)/gastroesophageal reflux (K21), and chronic kidney disease (N18) [<xref rid="pone.0274276.ref090" ref-type="bibr">90</xref>, <xref rid="pone.0274276.ref133" ref-type="bibr">133</xref>]. Three studies tackled suicidality (X60-X84) [<xref rid="pone.0274276.ref087" ref-type="bibr">87</xref>&#8211;<xref rid="pone.0274276.ref089" ref-type="bibr">89</xref>]. Lastly, one study addressed preeclampsia (O14) [<xref rid="pone.0274276.ref126" ref-type="bibr">126</xref>].</p></sec></sec><sec id="sec014"><title>Quality assessment</title><p>Quality was assessed using the PROBAST tool and 90.5% (n = 96 of 106) of the included studies were of high and unclear risk of bias (<xref rid="pone.0274276.g003" ref-type="fig">Fig 3</xref>). Analysis domain was the main source of bias, because of underreporting. It was found that only a few studies (n = 11) were reported in accordance with transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD) guidelines [<xref rid="pone.0274276.ref136" ref-type="bibr">136</xref>]. Nevertheless, studies of low risk of bias were downgraded to be of high risk of bias due to the of lack of external validation of the proposed models (n = 20). The second concern assessed using this tool was the concern of applicability, which was estimated as low to moderate concern (66%). The dependence of the predictive models on not-routine PHC data as a concern of models&#8217; applicability within PHC settings was raised in 34% of the studies.</p><fig position="float" id="pone.0274276.g003" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0274276.g003</object-id><label>Fig 3</label><caption><title>Percentage presentation of the results of (PROBAST) tool.</title><p>The tool has two components. Component 1. Risk of bias (4 domains: Participants, predictors, outcome, and analysis). Component 2. Concern of applicability (3 domains: Participants, predictors, and outcome).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0274276.g003.jpg"/></fig><p>Most of the included studies (n = 98 of 106, 92.5%) were published as peer-reviewed articles in biomedical (e.g., PLOS ONE, n = 8) and technical journals (e.g., IEEE, n = 3). Eight studies were preprint and abstracts. National research institutes and universities were the most frequently reported funding support. Most of the studies reported that the funders were not involved in the published work.</p></sec></sec><sec sec-type="conclusions" id="sec015"><title>Discussion</title><p>ML prediction models could have an immense potential to augment health practice and clinical decision making in various health sectors. Our systematic review provides an outline of the health conditions investigated with ML prediction models using PHC data.</p><sec id="sec016"><title>Summary of findings</title><p>In 106 observational studies, we identified 42 health conditions targeted by 207 ML prediction models, of which 42.5% were random forest and SVM. The included models used PHC data documented over the past 40 years for a total of 22.7 million patients. Half of the studies were conducted in the US and the UK. While the majority of the included studies (77.3%) focused on diagnosis prediction, a significant portion also addressed predictive aspects related to complications, hospitalization, and mortality. The most frequently targeted health conditions included Alzheimer&#8217;s disease, diabetes mellitus, heart failure, colorectal cancer, and chronic obstructive pulmonary diseases, while other conditions such as asthma, childhood obesity, and dyspepsia received comparatively less attention. A considerable portion of the models (76.4% of the included studies) were trained and internally validated without evaluating their generalizability.</p></sec><sec id="sec017"><title>Results in perspective</title><p>Detection and management of health conditions, particularly those that are preventable and controllable like diabetes mellitus, stand for the fundamental role of PHC [<xref rid="pone.0274276.ref003" ref-type="bibr">3</xref>]. Advances in such technologies might enhance health care and quality of life. Noticeably, they have gained more attention in many countries [<xref rid="pone.0274276.ref011" ref-type="bibr">11</xref>]. Our findings of common and rare health conditions targeted by ML prediction models in PHC indicates increase of research interest. However, clinical implication of such models is still limited to the theoretical good performance. Furthermore, the unequal distribution of publications across countries could be related to the low publication rate or lack of proper health data documentation systems in lower income countries, which impose further limitation to validate and implement such models.</p><p>The coding system used in health records does not universally follow the same criteria for all diseases, posing challenges for the consistency of models&#8217; performance [<xref rid="pone.0274276.ref137" ref-type="bibr">137</xref>]. Moreover, the lack of globally standardized definitions and terminology of diseases and the wide variability of the services provided across different health systems further limit the effectiveness of the models [<xref rid="pone.0274276.ref137" ref-type="bibr">137</xref>]. For example, uncoded free-text clinical notes as well as using &#8216;race&#8217; and &#8216;ethnicity&#8217; or &#8216;suicide&#8217; and &#8216;suicide attempts&#8217; to be documented as a single input can affect the predictive power of the models [<xref rid="pone.0274276.ref138" ref-type="bibr">138</xref>]. Other drawbacks reported include underrepresentation of healthy persons, retrospective temporal dimension of predictors, and the absence of confirmatory diagnostic services in PHC pose significant limitations [<xref rid="pone.0274276.ref139" ref-type="bibr">139</xref>, <xref rid="pone.0274276.ref140" ref-type="bibr">140</xref>].</p><p>Technical biases can significantly influence the clinical utility of technologies. Models trained on historical data without adaptation to policy changes may reinforce outdated practices, leading to erroneous results [<xref rid="pone.0274276.ref141" ref-type="bibr">141</xref>]. Additionally, validating models using different populations data can create a mismatch between the data or environment on which the models was trained; this mismatch may impact the accuracy of the models&#8217; prediction [<xref rid="pone.0274276.ref141" ref-type="bibr">141</xref>]. Therefore, documenting characteristics of the health systems may highlight the discrepancies between the data used to train and validate the models. This may improve the validation and implementation processes of the models. Models that are known for their high prediction accuracy, such as random forest and SVM might support better health outcomes when developed using high quality health data [<xref rid="pone.0274276.ref139" ref-type="bibr">139</xref>]. Additionally, the variety of the ML prediction models characteristics provide opportunities to improve healthcare practice. Using large data documented as electronic health records, random forest models and ensemble models such as boosting models have the ability to handle large datasets with numerous predictors variables [<xref rid="pone.0274276.ref140" ref-type="bibr">140</xref>]. Artificial neural network can also perform complex images processing that can boost the primary health care services [<xref rid="pone.0274276.ref140" ref-type="bibr">140</xref>]. Furthermore, SVM and decision tree models can provide nonlinear solutions, thus will support our understanding of complex and dynamic diseases for earlier health conditions prediction [<xref rid="pone.0274276.ref142" ref-type="bibr">142</xref>].</p><p>Nature of diseases append further challenges. The most challenging diseases for ML prediction are multifaceted long-term health conditions, such as DM, that are influenced by combination of genetic, environmental, and lifestyle factors. The complex health conditions further tangle the models, making it harder to identify accurate predictive patterns. Furthermore, the subjective nature of symptoms, especially symptoms related to mental health disorders, pose additive challenges toward ML models accuracy. Rare diseases, if documented, often suffer from limited data availability, leading to difficulty to train ML models effectively [<xref rid="pone.0274276.ref143" ref-type="bibr">143</xref>].</p><p>Health care professionals are fundamental to the process of implementing and integrating ML prediction models in their healthcare practice. Despite that, our review did not report outcomes related to healthcare professionals. Significant variability of opinions on the utilization of ML in PHC among primary health care providers hinder its acceptance. Furthermore, the black-box nature of ML prediction models precludes the clinical interpretability of models&#8217; outcomes. Additional workload and training are needed to implement such technology in the routine practice. Trust, data protection, and ethical and clinical responsibility legislation are further intractable issues that represent major obstacles toward ML prediction models implementation [<xref rid="pone.0274276.ref005" ref-type="bibr">5</xref>].</p><p>A considerable lack of usage of studies reporting guidelines across the included studies lead to deficient description of the populations&#8217; demographics and underreporting of the models&#8217; related statistical analysis, which lead to high risk of bias of majority of studies. These shortcomings negatively affect the reproducibility of the models [<xref rid="pone.0274276.ref144" ref-type="bibr">144</xref>]. Navarro and colleagues investigated this underreporting, and they claimed that the available reporting guidelines of modelling studies might be less apposite for ML models studies [<xref rid="pone.0274276.ref145" ref-type="bibr">145</xref>].</p></sec><sec id="sec018"><title>Implication of results and recommendation for future contributions</title><p>This review provided a comprehensive outline of ML prediction models in PHC and raises important considerations for future research and implementation of this technology in PHC settings. Interdisciplinary collaboration among health care workers, developers of ML models, and creators of digital documentation systems is required. This is especially important given the increasing popularity of digitally connected health systems [<xref rid="pone.0274276.ref005" ref-type="bibr">5</xref>]. It is recommended to augment the participation of health professionals through the development process of the PHC predictive models to critically evaluate, assess, adopt, and challenge the validation of the models within practices. This collaboration may assist ML engineers to recognize unintended negative implications of their algorithms, such as accidentally fitting of confounders, and unintended discriminatory bias, among others, for better health outcomes [<xref rid="pone.0274276.ref146" ref-type="bibr">146</xref>]. Health care systems need to provide comprehensive population health data repositories as an enabler for medical analyses [<xref rid="pone.0274276.ref137" ref-type="bibr">137</xref>]. Well-designed and -documented repositories which provide representative health data for the healthy and diseased populations are needed [<xref rid="pone.0274276.ref137" ref-type="bibr">137</xref>, <xref rid="pone.0274276.ref139" ref-type="bibr">139</xref>]. These high-quality data repositories might provide future modelling studies with data that match the studies&#8217; clinical research questions for more accurate prediction. Further ML prediction studies are needed to target more health conditions using PHC data. Despite the additional burden, it is beneficial also to continuously assess the potential significance of models, such as improved health outcomes, reduced medical errors, increased professional effectiveness and productivity, and enhanced patients&#8217; quality of life [<xref rid="pone.0274276.ref147" ref-type="bibr">147</xref>]. It is recommended to follow reporting guidelines for producing valid and reproducible ML modelling studies. Developing robust frameworks to enable the adoption and integration of ML models in the routine practice is also essential for effective transition from conventional health care systems to digital health [<xref rid="pone.0274276.ref148" ref-type="bibr">148</xref>, <xref rid="pone.0274276.ref149" ref-type="bibr">149</xref>]. Sophisticated technical infrastructure and strong academic and governmental support are essential for promoting and supporting long-term and broad-reaching PHC ML-based services [<xref rid="pone.0274276.ref138" ref-type="bibr">138</xref>, <xref rid="pone.0274276.ref150" ref-type="bibr">150</xref>]. However, balanced arguments [<xref rid="pone.0274276.ref151" ref-type="bibr">151</xref>, <xref rid="pone.0274276.ref152" ref-type="bibr">152</xref>] regarding the potential benefits and limitations of ML models support better health care without overestimating or hampering the use of such technology. It is also suggested to integrate the basic understanding of ML concepts and techniques in education programs for health science and medical students.</p></sec><sec id="sec019"><title>Strengths and limitations of the review</title><p>Our review was conducted following a predesigned comprehensive protocol [<xref rid="pone.0274276.ref021" ref-type="bibr">21</xref>]. We identified the health conditions targeted within PHC settings and identified the gaps that need to be addressed. The main limitation of our review is the low quality of evidence of the primary evidence. It is also possible due to the wide array of descriptors that exist to describe ML, our search strategy could have missed some studies if they exclusively used terms outside of our search string [<xref rid="pone.0274276.ref153" ref-type="bibr">153</xref>]. Limiting the scope of our review to clinical health conditions might have excluded other conditions, such as domestic violence and drug abuse [<xref rid="pone.0274276.ref003" ref-type="bibr">3</xref>]. Guiding our work using ICD-10 might have led to the exclusion of some health conditions, such as frailty studies [<xref rid="pone.0274276.ref154" ref-type="bibr">154</xref>]. Lastly, we did not present the statistical analysis of the models&#8217; attributes or conduct a meta-analysis, because of the broad heterogeneity across studies. In the future, we plan to update our review&#8211;considering the noticeable rise of ML studies within PHC, while also modifying our methodology to reduce the identified limitations. It is also planned to use the specific ML guidelines TRIPOD-AI and PROBAST-AI when published to strengthen quality and reporting of our findings [<xref rid="pone.0274276.ref155" ref-type="bibr">155</xref>].</p><p>In conclusion, ML prediction models within PHC are gaining traction. Further studies examining the use of ML in real PHC settings are needed, especially those with prospective designs and more representative samples. Collaborating amongst multidisciplinary teams to tackle ML in PHC will increase the confidence in models and their implementations in clinical practice.</p></sec></sec><sec id="sec020" sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="pone.0274276.s001" position="float" content-type="local-data" orientation="portrait"><label>S1 Table</label><caption><title>List of excluded studies with reasons (n = 58).</title><p>(PDF)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0274276.s001.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="pone.0274276.s002" position="float" content-type="local-data" orientation="portrait"><label>S2 Table</label><caption><title>Characteristics of the included ML predictive models.</title><p>(PDF)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0274276.s002.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="pone.0274276.s003" position="float" content-type="local-data" orientation="portrait"><label>S1 File</label><caption><title>Search strategy.</title><p>(PDF)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0274276.s003.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="pone.0274276.s004" position="float" content-type="local-data" orientation="portrait"><label>S2 File</label><caption><title>Prisma checklist.</title><p>(DOC)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0274276.s004.doc" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="pone.0274276.s005" position="float" content-type="local-data" orientation="portrait"><label>S1 Panel</label><caption><title>Quantitative summary of the included studies&#8217; characteristics (n = 106).</title><p>(PDF)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0274276.s005.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>Marcos Andr&#233; Gon&#231;alves, PhD and Bruna Zanotto, MSc, provided their feedback on the project&#8217;s primary draft. Luana Fiengo Tanaka, PhD, helped retrieved inaccessible studies.</p></ack><ref-list><title>References</title><ref id="pone.0274276.ref001"><label>1</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Aoki</surname><given-names>M.</given-names></name><article-title>Editorial: Science and roles of general medicine</article-title>. <source>Japanese J Natl Med Serv</source>. <year>2001</year>;<volume>55</volume>: <fpage>111</fpage>&#8211;<lpage>114</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.11261/iryo1946.55.111</pub-id></mixed-citation></ref><ref id="pone.0274276.ref002"><label>2</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Troncoso</surname><given-names>EL</given-names></name>. <article-title>The Greatest Challenge to Using AI/ML for Primary Health Care: Mindset or Datasets?</article-title><source>Front Artif Intell</source>. <year>2020</year>;<volume>3</volume>: <fpage>53</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/frai.2020.00053</pub-id><pub-id pub-id-type="pmid">33733170</pub-id><pub-id pub-id-type="pmcid">PMC7861302</pub-id></mixed-citation></ref><ref id="pone.0274276.ref003"><label>3</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hashim</surname><given-names>MJ</given-names></name>. <article-title>A definition of family medicine and general practice</article-title>. <source>J Coll Physicians Surg Pakistan</source>. <year>2018</year>;<volume>28</volume>: <fpage>76</fpage>&#8211;<lpage>77</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.29271/jcpsp.2018.01.76</pub-id><pub-id pub-id-type="pmid">29290201</pub-id></mixed-citation></ref><ref id="pone.0274276.ref004"><label>4</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cao</surname><given-names>L.</given-names></name><article-title>Data science: A comprehensive overview</article-title>. <source>ACM Comput Surv</source>. <year>2018</year>;<volume>50</volume>: <fpage>1</fpage>&#8211;<lpage>42</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1145/3076253</pub-id></mixed-citation></ref><ref id="pone.0274276.ref005"><label>5</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Liyanage</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Liaw</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Jonnagaddala</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Schreiber</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kuziemsky</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Terry</surname><given-names>AL</given-names></name>, <etal>et al</etal>. <article-title>Artificial Intelligence in Primary Health Care: Perceptions, Issues, and Challenges</article-title>. <source>Yearb Med Inform</source>. <year>2019</year>;<volume>28</volume>: <fpage>41</fpage>&#8211;<lpage>46</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1055/s-0039-1677901</pub-id><pub-id pub-id-type="pmid">31022751</pub-id><pub-id pub-id-type="pmcid">PMC6697547</pub-id></mixed-citation></ref><ref id="pone.0274276.ref006"><label>6</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Debray</surname><given-names>TPA</given-names></name>, <name name-style="western"><surname>Damen</surname><given-names>JAAG</given-names></name>, <name name-style="western"><surname>Snell</surname><given-names>KIE</given-names></name>, <name name-style="western"><surname>Ensor</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hooft</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Reitsma</surname><given-names>JB</given-names></name>, <etal>et al</etal>. <article-title>A guide to systematic review and meta-analysis of prediction model performance</article-title>. <source>BMJ</source>. <year>2017</year>;<volume>356</volume>: <fpage>i6460</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.i6460</pub-id><pub-id pub-id-type="pmid">28057641</pub-id></mixed-citation></ref><ref id="pone.0274276.ref007"><label>7</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sarker</surname><given-names>IH</given-names></name>. <article-title>Machine Learning: Algorithms, Real-World Applications and Research Directions</article-title>. <source>SN Comput Sci</source>. <year>2021</year>;<volume>2</volume>: <fpage>160</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s42979-021-00592-x</pub-id><pub-id pub-id-type="pmid">33778771</pub-id><pub-id pub-id-type="pmcid">PMC7983091</pub-id></mixed-citation></ref><ref id="pone.0274276.ref008"><label>8</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Do Nascimento</surname><given-names>IJB</given-names></name>, <name name-style="western"><surname>Marcolino</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Abdulazeem</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Weerasekara</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Azzopardi-Muscat</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Goncalves</surname><given-names>MA</given-names></name>, <etal>et al</etal>. <article-title>Impact of big data analytics on people&#8217;s health: Overview of systematic reviews and recommendations for future studies</article-title>. <source>J Med Internet Res</source>. <year>2021</year>;<volume>23</volume>: <fpage>e27275</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2196/27275</pub-id><pub-id pub-id-type="pmid">33847586</pub-id><pub-id pub-id-type="pmcid">PMC8080139</pub-id></mixed-citation></ref><ref id="pone.0274276.ref009"><label>9</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Marcus</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Sewell</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Balzer</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Krakower</surname><given-names>DS</given-names></name>. <article-title>Artificial Intelligence and Machine Learning for HIV Prevention: Emerging Approaches to Ending the Epidemic</article-title>. <source>Curr HIV/AIDS Rep</source>. <year>2020</year>;<volume>17</volume>: <fpage>171</fpage>&#8211;<lpage>179</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s11904-020-00490-6</pub-id><pub-id pub-id-type="pmid">32347446</pub-id><pub-id pub-id-type="pmcid">PMC7260108</pub-id></mixed-citation></ref><ref id="pone.0274276.ref010"><label>10</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Amaratunga</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Cabrera</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sargsyan</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kostis</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Zinonos</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kostis</surname><given-names>WJ</given-names></name>. <article-title>Uses and opportunities for machine learning in hypertension research</article-title>. <source>Int J Cardiol Hypertens</source>. <year>2020</year>;<volume>5</volume>: <fpage>100027</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ijchy.2020.100027</pub-id><pub-id pub-id-type="pmid">33447756</pub-id><pub-id pub-id-type="pmcid">PMC7803038</pub-id></mixed-citation></ref><ref id="pone.0274276.ref011"><label>11</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kavakiotis</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Tsave</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Salifoglou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Maglaveras</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Vlahavas</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Chouvarda</surname><given-names>I</given-names></name>. <article-title>Machine Learning and Data Mining Methods in Diabetes Research</article-title>. <source>Comput Struct Biotechnol J</source>. <year>2017</year>;<volume>15</volume>: <fpage>104</fpage>&#8211;<lpage>116</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.csbj.2016.12.005</pub-id><pub-id pub-id-type="pmid">28138367</pub-id><pub-id pub-id-type="pmcid">PMC5257026</pub-id></mixed-citation></ref><ref id="pone.0274276.ref012"><label>12</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sufriyana</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Husnayain</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>YL</given-names></name>, <name name-style="western"><surname>Kuo</surname><given-names>CY</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Yeh</surname><given-names>TY</given-names></name>, <etal>et al</etal>. <article-title>Comparison of multivariable logistic regression and other machine learning algorithms for prognostic prediction studies in pregnancy care: Systematic review and meta-analysis</article-title>. <source>JMIR Med Informatics</source>. <year>2020</year>;<volume>8</volume>: <fpage>e16503</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2196/16503</pub-id><pub-id pub-id-type="pmid">33200995</pub-id><pub-id pub-id-type="pmcid">PMC7708089</pub-id></mixed-citation></ref><ref id="pone.0274276.ref013"><label>13</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Rajpara</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Botello</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Townend</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ormerod</surname><given-names>AD</given-names></name>. <article-title>Systematic review of dermoscopy and digital dermoscopy/ artificial intelligence for the diagnosis of melanoma</article-title>. <source>Br J Dermatol</source>. <year>2009</year>;<volume>161</volume>: <fpage>591</fpage>&#8211;<lpage>604</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1365-2133.2009.09093.x</pub-id><pub-id pub-id-type="pmid">19302072</pub-id></mixed-citation></ref><ref id="pone.0274276.ref014"><label>14</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Kiik</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Peek</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Curcin</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Marshall</surname><given-names>IJ</given-names></name>, <name name-style="western"><surname>Rudd</surname><given-names>AG</given-names></name>, <etal>et al</etal>. <article-title>A systematic review of machine learning models for predicting outcomes of stroke with structured data</article-title>. <source>PLoS One</source>. <year>2020</year>;<volume>15</volume>: <fpage>e0234722</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0234722</pub-id><pub-id pub-id-type="pmid">32530947</pub-id><pub-id pub-id-type="pmcid">PMC7292406</pub-id></mixed-citation></ref><ref id="pone.0274276.ref015"><label>15</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Contreras</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Vehi</surname><given-names>J</given-names></name>. <article-title>Artificial intelligence for diabetes management and decision support: Literature review</article-title>. <source>J Med Internet Res</source>. <year>2018</year>;<volume>20</volume>: <fpage>e10775</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2196/10775</pub-id><pub-id pub-id-type="pmid">29848472</pub-id><pub-id pub-id-type="pmcid">PMC6000484</pub-id></mixed-citation></ref><ref id="pone.0274276.ref016"><label>16</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Rahimi</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>L&#233;gar&#233;</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Archambault</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zomahoun</surname><given-names>HTV</given-names></name>, <name name-style="western"><surname>Chandavong</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Application of artificial intelligence in community-based primary health care: Systematic scoping review and critical appraisal</article-title>. <source>Journal of Medical Internet Research J Med Internet Res</source>; <month>Sep</month><volume>1</volume>, <fpage>2021</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2196/29839</pub-id><pub-id pub-id-type="pmid">34477556</pub-id><pub-id pub-id-type="pmcid">PMC8449300</pub-id></mixed-citation></ref><ref id="pone.0274276.ref017"><label>17</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kueper</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Terry</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Zwarenstein</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lizotte</surname><given-names>DJ</given-names></name>. <article-title>Artificial intelligence and primary care research: A scoping review</article-title>. <source>Ann Fam Med</source>. <year>2020</year>;<volume>18</volume>: <fpage>250</fpage>&#8211;<lpage>258</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1370/afm.2518</pub-id><pub-id pub-id-type="pmid">32393561</pub-id><pub-id pub-id-type="pmcid">PMC7213996</pub-id></mixed-citation></ref><ref id="pone.0274276.ref018"><label>18</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Andaur Navarro</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Damen</surname><given-names>JAAG</given-names></name>, <name name-style="western"><surname>Takada</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nijman</surname><given-names>SWJ</given-names></name>, <name name-style="western"><surname>Dhiman</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Protocol for a systematic review on the methodological and reporting quality of prediction model studies using machine learning techniques</article-title>. <source>BMJ Open</source>. <year>2020</year>;<volume>10</volume>: <fpage>e038832</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmjopen-2020-038832</pub-id><pub-id pub-id-type="pmid">33177137</pub-id><pub-id pub-id-type="pmcid">PMC7661369</pub-id></mixed-citation></ref><ref id="pone.0274276.ref019"><label>19</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Page</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>McKenzie</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Bossuyt</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Boutron</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Hoffmann</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Mulrow</surname><given-names>CD</given-names></name>, <etal>et al</etal>. <article-title>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</article-title>. <source>The BMJ. British Medical Journal Publishing Group</source>; <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmid">33782057</pub-id><pub-id pub-id-type="pmcid">PMC8005924</pub-id></mixed-citation></ref><ref id="pone.0274276.ref020"><label>20</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Moons</surname><given-names>KGM</given-names></name>, <name name-style="western"><surname>de Groot</surname><given-names>JAH</given-names></name>, <name name-style="western"><surname>Bouwmeester</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Vergouwe</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Mallett</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name>, <etal>et al</etal>. <article-title>Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist</article-title>. <source>PLoS Med</source>. <year>2014</year>;<volume>11</volume>: <fpage>e1001744</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pmed.1001744</pub-id><pub-id pub-id-type="pmid">25314315</pub-id><pub-id pub-id-type="pmcid">PMC4196729</pub-id></mixed-citation></ref><ref id="pone.0274276.ref021"><label>21</label><mixed-citation publication-type="other">Abdulazeem H, Whitelaw S, Schauberger G, Klug S. Development and Performance of Prediction Machine Learning Models supplied by Real-World Primary Health Care Data: A Systematic Review and Meta-analysis. In: PROSPERO 2021 CRD42021264582 [Internet]. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021264582" ext-link-type="uri">https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021264582</ext-link></mixed-citation></ref><ref id="pone.0274276.ref022"><label>22</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ouzzani</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hammady</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fedorowicz</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Elmagarmid</surname><given-names>A</given-names></name>. <article-title>Rayyan-a web and mobile app for systematic reviews</article-title>. <source>Syst Rev</source>. <year>2016</year>;<volume>5</volume>: <fpage>210</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s13643-016-0384-4</pub-id><pub-id pub-id-type="pmid">27919275</pub-id><pub-id pub-id-type="pmcid">PMC5139140</pub-id></mixed-citation></ref><ref id="pone.0274276.ref023"><label>23</label><mixed-citation publication-type="other">World Health Organization. ICD-10 Version:2019. In: International Classification of Diseases [Internet]. 2019 [cited 1 Sep 2021]. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://icd.who.int/browse10/2019/en#/XIV" ext-link-type="uri">https://icd.who.int/browse10/2019/en#/XIV</ext-link></mixed-citation></ref><ref id="pone.0274276.ref024"><label>24</label><mixed-citation publication-type="other">International Classification of Diseases (ICD). [cited 6 Apr 2023]. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/standards/classifications/classification-of-diseases" ext-link-type="uri">https://www.who.int/standards/classifications/classification-of-diseases</ext-link></mixed-citation></ref><ref id="pone.0274276.ref025"><label>25</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Moons</surname><given-names>KGM</given-names></name>, <name name-style="western"><surname>Wolff</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>Riley</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Whiting</surname><given-names>PF</given-names></name>, <name name-style="western"><surname>Westwood</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>GS</given-names></name>, <etal>et al</etal>. <article-title>PROBAST: A tool to assess risk of bias and applicability of prediction model studies: Explanation and elaboration</article-title>. <source>Ann Intern Med</source>. <year>2019</year>;<volume>170</volume>: <fpage>W1</fpage>&#8211;<lpage>W33</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.7326/M18-1377</pub-id><pub-id pub-id-type="pmid">30596876</pub-id></mixed-citation></ref><ref id="pone.0274276.ref026"><label>26</label><mixed-citation publication-type="journal"><name name-style="western"><surname>S&#225;enz Bajo</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Barrios Rueda</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Conde G&#243;mez</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dom&#237;nguez Mac&#237;as</surname><given-names>I</given-names></name>, <name name-style="western"><surname>L&#243;pez Caraba&#241;o</surname><given-names>A</given-names></name>, <name name-style="western"><surname>M&#233;ndez D&#237;ez</surname><given-names>C</given-names></name>. <article-title>Use of neural networks in medicine: concerning dyspeptic pathology</article-title>. <source>Aten Primaria</source>. <year>2002</year>;<volume>30</volume>: <fpage>99</fpage>&#8211;<lpage>102</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0212-6567(02)78978-6</pub-id><pub-id pub-id-type="pmid">12106560</pub-id><pub-id pub-id-type="pmcid">PMC7679651</pub-id></mixed-citation></ref><ref id="pone.0274276.ref027"><label>27</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Herrett</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gallagher</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Bhaskaran</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Forbes</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mathur</surname><given-names>R</given-names></name>, <name name-style="western"><surname>van Staa</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Data Resource Profile: Clinical Practice Research Datalink (CPRD)</article-title>. <source>Int J Epidemiol</source>. <year>2015</year>;<volume>44</volume>: <fpage>827</fpage>&#8211;<lpage>836</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ije/dyv098</pub-id><pub-id pub-id-type="pmid">26050254</pub-id><pub-id pub-id-type="pmcid">PMC4521131</pub-id></mixed-citation></ref><ref id="pone.0274276.ref028"><label>28</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tsang</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>X</given-names></name>. <article-title>Modeling Large Sparse Data for Feature Selection: Hospital Admission Predictions of the Dementia Patients Using Primary Care Electronic Health Records</article-title>. <source>IEEE J Transl Eng Heal Med</source>. <year>2021</year>;<volume>9</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1109/JTEHM.2020.3040236</pub-id><pub-id pub-id-type="pmid">33354439</pub-id><pub-id pub-id-type="pmcid">PMC7737850</pub-id></mixed-citation></ref><ref id="pone.0274276.ref029"><label>29</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Karapetyan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Linde</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Donnachie</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hapfelmeier</surname><given-names>A</given-names></name>. <article-title>SARS-CoV-2 infection and cardiovascular or pulmonary complications in ambulatory care: A risk assessment based on routine data</article-title>. <source>PLoS One</source>. <year>2021</year>;<volume>16</volume>: <fpage>e0258914</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0258914</pub-id><pub-id pub-id-type="pmid">34673818</pub-id><pub-id pub-id-type="pmcid">PMC8530335</pub-id></mixed-citation></ref><ref id="pone.0274276.ref030"><label>30</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Boaz</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Samuel</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Elena</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nurit</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Brianna</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Rand</surname><given-names>W</given-names></name>, <etal>et al</etal>. <article-title>Machine Learning Detection of Cognitive Impairment in Primary Care</article-title>. <source>Alzheimers Dis Dement</source>. <year>2017</year>;<volume>1</volume>: <fpage>S111</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.36959/734/372</pub-id></mixed-citation></ref><ref id="pone.0274276.ref031"><label>31</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Akyea</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Qureshi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kai</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Weng</surname><given-names>SF</given-names></name>. <article-title>Performance and clinical utility of supervised machine-learning approaches in detecting familial hypercholesterolaemia in primary care</article-title>. <source>NPJ Digit Med</source>. <year>2020</year>;<volume>3</volume>: <fpage>142</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41746-020-00349-5</pub-id><pub-id pub-id-type="pmid">33145438</pub-id><pub-id pub-id-type="pmcid">PMC7603302</pub-id></mixed-citation></ref><ref id="pone.0274276.ref032"><label>32</label><mixed-citation publication-type="other">Kaplan A, Cao H, Fitzgerald JM, Yang E, Iannotti N, Kocks JWH, et al. Asthma/COPD Differentiation Classification (AC/DC): Machine Learning to Aid Physicians in Diagnosing Asthma, COPD and Asthma-COPD Overlap (ACO). D22 COMORBIDITIES IN PEOPLE WITH COPD. American Thoracic Society; 2020. p. A6285.</mixed-citation></ref><ref id="pone.0274276.ref033"><label>33</label><mixed-citation publication-type="journal"><name name-style="western"><surname>St&#228;llberg</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lisspers</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Larsson</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Janson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>M&#252;ller</surname><given-names>M</given-names></name>, <name name-style="western"><surname>&#321;uczko</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Predicting hospitalization due to copd exacerbations in swedish primary care patients using machine learning&#8211;based on the arctic study</article-title>. <source>Int J COPD</source>. <year>2021</year>;<volume>16</volume>: <fpage>677</fpage>&#8211;<lpage>688</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2147/COPD.S293099</pub-id><pub-id pub-id-type="pmid">33758504</pub-id><pub-id pub-id-type="pmcid">PMC7981164</pub-id></mixed-citation></ref><ref id="pone.0274276.ref034"><label>34</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Perveen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shahbaz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Keshavjee</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Guergachi</surname><given-names>A</given-names></name>. <article-title>Prognostic Modeling and Prevention of Diabetes Using Machine Learning Technique</article-title>. <source>Sci Rep</source>. <year>2019</year>;<volume>9</volume>: <fpage>13805</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-019-49563-6</pub-id><pub-id pub-id-type="pmid">31551457</pub-id><pub-id pub-id-type="pmcid">PMC6760163</pub-id></mixed-citation></ref><ref id="pone.0274276.ref035"><label>35</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Raket</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Jaskolowski</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kinon</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Brasen</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>J&#246;nsson</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wehnert</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first episode of psychosis: a case-control development and validation study</article-title>. <source>Lancet Digit Heal</source>. <year>2020</year>;<volume>2</volume>: <fpage>e229</fpage>&#8211;<lpage>e239</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2589-7500(20)30024-8</pub-id><pub-id pub-id-type="pmid">33328055</pub-id></mixed-citation></ref><ref id="pone.0274276.ref036"><label>36</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sekelj</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sandler</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Johnston</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Pollock</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Hill</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Gordon</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Detecting undiagnosed atrial fibrillation in UK primary care: Validation of a machine learning prediction algorithm in a retrospective cohort study</article-title>. <source>Eur J Prev Cardiol</source>. <year>2021</year>;<volume>28</volume>: <fpage>598</fpage>&#8211;<lpage>605</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/2047487320942338</pub-id><pub-id pub-id-type="pmid">34021576</pub-id></mixed-citation></ref><ref id="pone.0274276.ref037"><label>37</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kostev</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chaudhuri</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tanislav</surname><given-names>C</given-names></name>. <article-title>Predicting the risk of stroke in patients with late-onset epilepsy: A machine learning approach</article-title>. <source>Epilepsy Behav</source>. <year>2021</year>;<volume>122</volume>: <fpage>108211</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.yebeh.2021.108211</pub-id><pub-id pub-id-type="pmid">34325155</pub-id></mixed-citation></ref><ref id="pone.0274276.ref038"><label>38</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Birks</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bankhead</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Holt</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Fuller</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Patnick</surname><given-names>J</given-names></name>. <article-title>Evaluation of a prediction model for colorectal cancer: retrospective analysis of 2.5 million patient records</article-title>. <source>Cancer Med</source>. <year>2017</year>;<volume>6</volume>: <fpage>2453</fpage>&#8211;<lpage>2460</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/cam4.1183</pub-id><pub-id pub-id-type="pmid">28941187</pub-id><pub-id pub-id-type="pmcid">PMC5633543</pub-id></mixed-citation></ref><ref id="pone.0274276.ref039"><label>39</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Myers</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Knowles</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Staszak</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Shapiro</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Howard</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Yadava</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Precision screening for familial hypercholesterolaemia: a machine learning study applied to electronic health encounter data</article-title>. <source>Lancet Digit Heal</source>. <year>2019</year>;<volume>1</volume>: <fpage>e393</fpage>&#8211;<lpage>e402</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2589-7500(19)30150-5</pub-id><pub-id pub-id-type="pmid">33323221</pub-id><pub-id pub-id-type="pmcid">PMC8086528</pub-id></mixed-citation></ref><ref id="pone.0274276.ref040"><label>40</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bielinski</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Decker</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Chamberlain</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Roger</surname><given-names>VL</given-names></name>, <etal>et al</etal>. <article-title>Abstract P259: Using Natural Language Processing and Machine Learning to Identify Incident Stroke From Electronic Health Records</article-title>. <source>Circulation</source>. <year>2020</year>;<volume>141</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/circ.141.suppl_1.p259</pub-id><pub-id pub-id-type="pmcid">PMC7985804</pub-id><pub-id pub-id-type="pmid">33683212</pub-id></mixed-citation></ref><ref id="pone.0274276.ref041"><label>41</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lisspers</surname><given-names>K</given-names></name>, <name name-style="western"><surname>St&#228;llberg</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Larsson</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Janson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>M&#252;ller</surname><given-names>M</given-names></name>, <name name-style="western"><surname>&#321;uczko</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Developing a short-term prediction model for asthma exacerbations from Swedish primary care patients&#8217; data using machine learning&#8212;Based on the ARCTIC study</article-title>. <source>Respir Med</source>. <year>2021</year>;<volume>185</volume>: <fpage>106483</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.rmed.2021.106483</pub-id><pub-id pub-id-type="pmid">34077873</pub-id></mixed-citation></ref><ref id="pone.0274276.ref042"><label>42</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Marin-Gomez</surname><given-names>FX</given-names></name>, <name name-style="western"><surname>F&#224;bregas-Escurriola</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Segu&#237;</surname><given-names>FL</given-names></name>, <name name-style="western"><surname>P&#233;rez</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>Camps</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Pe&#241;a</surname><given-names>JM</given-names></name>, <etal>et al</etal>. <article-title>Assessing the likelihood of contracting COVID-19 disease based on a predictive tree model: A retrospective cohort study</article-title>. <source>PLoS One</source>. <year>2021</year>;<volume>16</volume>: <fpage>e0247995</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0247995</pub-id><pub-id pub-id-type="pmid">33657164</pub-id><pub-id pub-id-type="pmcid">PMC7928490</pub-id></mixed-citation></ref><ref id="pone.0274276.ref043"><label>43</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Trtica-Majnaric</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zekic-Susac</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sarlija</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Vitale</surname><given-names>B</given-names></name>. <article-title>Prediction of influenza vaccination outcome by neural networks and logistic regression</article-title>. <source>J Biomed Inform</source>. <year>2010</year>;<volume>43</volume>: <fpage>774</fpage>&#8211;<lpage>781</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jbi.2010.04.011</pub-id><pub-id pub-id-type="pmid">20451660</pub-id></mixed-citation></ref><ref id="pone.0274276.ref044"><label>44</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zafari</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Langlois</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zulkernine</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kosowan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Singer</surname><given-names>A</given-names></name>. <article-title>AI in predicting COPD in the Canadian population</article-title>. <source>BioSystems</source>. <year>2022</year>;<volume>211</volume>: <fpage>104585</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.biosystems.2021.104585</pub-id><pub-id pub-id-type="pmid">34864143</pub-id></mixed-citation></ref><ref id="pone.0274276.ref045"><label>45</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shah</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Denaxas</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dobson</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hemingway</surname><given-names>H</given-names></name>. <article-title>Natural language processing for disease phenotyping in UK primary care records for research: A pilot study in myocardial infarction and death</article-title>. <source>J Biomed Semantics</source>. <year>2019</year>;<volume>10</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s13326-019-0214-4</pub-id><pub-id pub-id-type="pmid">31711543</pub-id><pub-id pub-id-type="pmcid">PMC6849160</pub-id></mixed-citation></ref><ref id="pone.0274276.ref046"><label>46</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Verbraak</surname><given-names>FD</given-names></name>, <name name-style="western"><surname>Abramoff</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Bausch</surname><given-names>GCF</given-names></name>, <name name-style="western"><surname>Klaver</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Nijpels</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schlingemann</surname><given-names>RO</given-names></name>, <etal>et al</etal>. <article-title>Diagnostic accuracy of a device for the automated detection of diabetic retinopathy in a primary care setting</article-title>. <source>Diabetes Care</source>. <year>2019</year>;<volume>42</volume>: <fpage>651</fpage>&#8211;<lpage>656</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2337/dc18-0148</pub-id><pub-id pub-id-type="pmid">30765436</pub-id></mixed-citation></ref><ref id="pone.0274276.ref047"><label>47</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hornbrook</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Goshen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Choman</surname><given-names>E</given-names></name>, <name name-style="western"><surname>O&#8217;Keeffe-Rosetti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kinar</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liles</surname><given-names>EG</given-names></name>, <etal>et al</etal>. <article-title>Early Colorectal Cancer Detected by Machine Learning Model Using Gender, Age, and Complete Blood Count Data</article-title>. <source>Dig Dis Sci</source>. <year>2017</year>;<volume>62</volume>: <fpage>2719</fpage>&#8211;<lpage>2727</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10620-017-4722-8</pub-id><pub-id pub-id-type="pmid">28836087</pub-id></mixed-citation></ref><ref id="pone.0274276.ref048"><label>48</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kinar</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Akiva</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Choman</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kariv</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Shalev</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Levin</surname><given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Performance analysis of a machine learning flagging system used to identify a group of individuals at a high risk for colorectal cancer</article-title>. <source>PLoS One</source>. <year>2017</year>;<volume>12</volume>: <fpage>e0171759</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0171759</pub-id><pub-id pub-id-type="pmid">28182647</pub-id><pub-id pub-id-type="pmcid">PMC5300225</pub-id></mixed-citation></ref><ref id="pone.0274276.ref049"><label>49</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hertroijs</surname><given-names>DFL</given-names></name>, <name name-style="western"><surname>Elissen</surname><given-names>AMJ</given-names></name>, <name name-style="western"><surname>Brouwers</surname><given-names>MCGJ</given-names></name>, <name name-style="western"><surname>Schaper</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>K&#246;hler</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Popa</surname><given-names>MC</given-names></name>, <etal>et al</etal>. <article-title>A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes</article-title>. <source>Diabetes, Obes Metab</source>. <year>2018</year>;<volume>20</volume>: <fpage>681</fpage>&#8211;<lpage>688</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/dom.13148</pub-id><pub-id pub-id-type="pmid">29095564</pub-id><pub-id pub-id-type="pmcid">PMC5836941</pub-id></mixed-citation></ref><ref id="pone.0274276.ref050"><label>50</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Pakhomov</surname><given-names>SVS</given-names></name>, <name name-style="western"><surname>Hanson</surname><given-names>PL</given-names></name>, <name name-style="western"><surname>Bjornsen</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>SA</given-names></name>. <article-title>Automatic Classification of Foot Examination Findings Using Clinical Notes and Machine Learning</article-title>. <source>J Am Med Informatics Assoc</source>. <year>2008</year>;<volume>15</volume>: <fpage>198</fpage>&#8211;<lpage>202</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1197/jamia.M2585</pub-id><pub-id pub-id-type="pmid">18096902</pub-id><pub-id pub-id-type="pmcid">PMC2274799</pub-id></mixed-citation></ref><ref id="pone.0274276.ref051"><label>51</label><mixed-citation publication-type="other">Stephens KA, Au MA, Yetisgen M, Lutz B, Suchsland MZ, Ebell MH, et al. Leveraging UMLS-driven NLP to enhance identification of influenza predictors derived from electronic medical record data. In: BioRxiv [preprint] [Internet]. 2020 [cited 4 Jan 2022].</mixed-citation></ref><ref id="pone.0274276.ref052"><label>52</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tseng</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Rouhizadeh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Maruthur</surname><given-names>NM</given-names></name>. <article-title>Analysis of Primary Care Provider Electronic Health Record Notes for Discussions of Prediabetes Using Natural Language Processing Methods</article-title>. <source>J Gen Intern Med</source>. <year>2021</year>;<volume>35</volume>: <fpage>S11</fpage>&#8211;<lpage>S12</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s11606-020-06400-1</pub-id><pub-id pub-id-type="pmid">33469758</pub-id></mixed-citation></ref><ref id="pone.0274276.ref053"><label>53</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>WF</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>X</given-names></name>. <article-title>Recurrent neural networks for early detection of heart failure from longitudinal electronic health record data: Implications for temporal modeling with respect to time before diagnosis, data density, data quantity, and data type</article-title>. <source>Circ Cardiovasc Qual Outcomes</source>. <year>2019</year>;<volume>12</volume>: <fpage>e005114</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.118.005114</pub-id><pub-id pub-id-type="pmid">31610714</pub-id><pub-id pub-id-type="pmcid">PMC6814386</pub-id></mixed-citation></ref><ref id="pone.0274276.ref054"><label>54</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Choi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Schuetz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>WF</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>J</given-names></name>. <article-title>Using recurrent neural network models for early detection of heart failure onset</article-title>. <source>J Am Med Informatics Assoc</source>. <year>2017</year>;<volume>24</volume>: <fpage>361</fpage>&#8211;<lpage>370</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/jamia/ocw112</pub-id><pub-id pub-id-type="pmid">27521897</pub-id><pub-id pub-id-type="pmcid">PMC5391725</pub-id></mixed-citation></ref><ref id="pone.0274276.ref055"><label>55</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Du</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Accurate prediction of coronary heart disease for patients with hypertension from electronic health records with big data and machine-learning methods: Model development and performance evaluation</article-title>. <source>JMIR Med Informatics</source>. <year>2020</year>;<volume>8</volume>: <fpage>e17257</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2196/17257</pub-id><pub-id pub-id-type="pmid">32628616</pub-id><pub-id pub-id-type="pmcid">PMC7381262</pub-id></mixed-citation></ref><ref id="pone.0274276.ref056"><label>56</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Farran</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Channanath</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Behbehani</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Thanaraj</surname><given-names>TA</given-names></name>. <article-title>Predictive models to assess risk of type 2 diabetes, hypertension and comorbidity: Machine-learning algorithms and validation using national health data from Kuwait-a cohort study</article-title>. <source>BMJ Open</source>. <year>2013</year>;<volume>3</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmjopen-2012-002457</pub-id><pub-id pub-id-type="pmid">23676796</pub-id><pub-id pub-id-type="pmcid">PMC3657675</pub-id></mixed-citation></ref><ref id="pone.0274276.ref057"><label>57</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hill</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Ayoubkhani</surname><given-names>D</given-names></name>, <name name-style="western"><surname>McEwan</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sugrue</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Farooqui</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Lister</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Predicting atrial fibrillation in primary care using machine learning</article-title>. <source>PLoS One</source>. <year>2019</year>;<volume>14</volume>: <fpage>e0224582</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0224582</pub-id><pub-id pub-id-type="pmid">31675367</pub-id><pub-id pub-id-type="pmcid">PMC6824570</pub-id></mixed-citation></ref><ref id="pone.0274276.ref058"><label>58</label><mixed-citation publication-type="other">LaFreniere D, Zulkernine F, Barber D, Martin K. Using machine learning to predict hypertension from a clinical dataset. 2016 IEEE Symposium Series on Computational Intelligence (SSCI). IEEE; 2016. pp. 1&#8211;7.</mixed-citation></ref><ref id="pone.0274276.ref059"><label>59</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sperrin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ashcroft</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Van Staa</surname><given-names>TP</given-names></name>. <article-title>Consistency of variety of machine learning and statistical models in predicting clinical risks of individual patients: Longitudinal cohort study using cardiovascular disease as exemplar</article-title>. <source>BMJ</source>. <year>2020</year>;<volume>371</volume>: <fpage>m3919</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.m3919</pub-id><pub-id pub-id-type="pmid">33148619</pub-id><pub-id pub-id-type="pmcid">PMC7610202</pub-id></mixed-citation></ref><ref id="pone.0274276.ref060"><label>60</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lip</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mccallum</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Reddy</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chandrasekaran</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Tule</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bhaskar</surname><given-names>RK</given-names></name>, <etal>et al</etal>. <article-title>Machine Learning Based Models for Predicting White-Coat and Masked Patterns of Blood Pressure</article-title>. <source>J Hypertens</source>. <year>2021</year>;<volume>39</volume>: <fpage>e69</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/01.hjh.0000745092.07595.a5</pub-id></mixed-citation></ref><ref id="pone.0274276.ref061"><label>61</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lorenzoni</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sabato</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Lanera</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bottigliengo</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Minto</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ocagli</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Comparison of machine learning techniques for prediction of hospitalization in heart failure patients</article-title>. <source>J Clin Med</source>. 2019/08/28. <year>2019</year>;<volume>8</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/jcm8091298</pub-id><pub-id pub-id-type="pmid">31450546</pub-id><pub-id pub-id-type="pmcid">PMC6780582</pub-id></mixed-citation></ref><ref id="pone.0274276.ref062"><label>62</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ng</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Steinhubl</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Defilippi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dey</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>WF</given-names></name>. <article-title>Early Detection of Heart Failure Using Electronic Health Records: Practical Implications for Time before Diagnosis, Data Diversity, Data Quantity, and Data Density</article-title>. <source>Circ Cardiovasc Qual Outcomes</source>. <year>2016</year>;<volume>9</volume>: <fpage>649</fpage>&#8211;<lpage>658</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.116.002797</pub-id><pub-id pub-id-type="pmid">28263940</pub-id><pub-id pub-id-type="pmcid">PMC5341145</pub-id></mixed-citation></ref><ref id="pone.0274276.ref063"><label>63</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nikolaou</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Massaro</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Garn</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Fakhimi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stergioulas</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Price</surname><given-names>D</given-names></name>. <article-title>The cardiovascular phenotype of Chronic Obstructive Pulmonary Disease (COPD): Applying machine learning to the prediction of cardiovascular comorbidities</article-title>. <source>Respir Med</source>. 2021/07/15. <year>2021</year>;<volume>186</volume>: <fpage>106528</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.rmed.2021.106528</pub-id><pub-id pub-id-type="pmid">34260974</pub-id></mixed-citation></ref><ref id="pone.0274276.ref064"><label>64</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sarraju</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Scheinker</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rodr&#237;guez</surname><given-names>F</given-names></name>. <article-title>Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients</article-title>. <source>Open Hear</source>. <year>2021</year>;<volume>8</volume>: <fpage>e001802</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/openhrt-2021-001802</pub-id><pub-id pub-id-type="pmid">34667093</pub-id><pub-id pub-id-type="pmcid">PMC8527119</pub-id></mixed-citation></ref><ref id="pone.0274276.ref065"><label>65</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Selskyy</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Vakulenko</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Televiak</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Veresiuk</surname><given-names>T</given-names></name>. <article-title>On an algorithm for decision-making for the optimization of disease prediction at the primary health care level using neural network clustering</article-title>. <source>Fam Med Prim Care Rev</source>. <year>2018</year>;<volume>20</volume>: <fpage>171</fpage>&#8211;<lpage>175</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.5114/fmpcr.2018.76463</pub-id></mixed-citation></ref><ref id="pone.0274276.ref066"><label>66</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Solanki</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ajmal</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Herman</surname><given-names>D</given-names></name>. <article-title>Abstract P185: Using Electronic Health Records To Identify Patients With Apparent Treatment Resistant Hypertension</article-title>. <source>Hypertension</source>. <year>2020</year>;<volume>76</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/hyp.76.suppl_1.p185</pub-id></mixed-citation></ref><ref id="pone.0274276.ref067"><label>67</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ayala Solares</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Canoy</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Raimondi</surname><given-names>FED</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hassaine</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Salimi-Khorshidi</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Long-Term Exposure to Elevated Systolic Blood Pressure in Predicting Incident Cardiovascular Disease: Evidence From Large-Scale Routine Electronic Health Records</article-title>. <source>J Am Heart Assoc</source>. <year>2019</year>;<volume>8</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/JAHA.119.012129</pub-id><pub-id pub-id-type="pmid">31164039</pub-id><pub-id pub-id-type="pmcid">PMC6645648</pub-id></mixed-citation></ref><ref id="pone.0274276.ref068"><label>68</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ward</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sarraju</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Harrington</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Heidenreich</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Machine learning and atherosclerotic cardiovascular disease risk prediction in a multi-ethnic population</article-title>. <source>NPJ Digit Med</source>. <year>2020</year>;<volume>3</volume>: <fpage>125</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41746-020-00331-1</pub-id><pub-id pub-id-type="pmid">33043149</pub-id><pub-id pub-id-type="pmcid">PMC7511400</pub-id></mixed-citation></ref><ref id="pone.0274276.ref069"><label>69</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Weng</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Reps</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kai</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Garibaldi</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Qureshi</surname><given-names>N</given-names></name>. <article-title>Can Machine-learning improve cardiovascular risk prediction using routine clinical data?</article-title><source>PLoS One</source>. <year>2017</year>;<volume>12</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0174944</pub-id><pub-id pub-id-type="pmid">28376093</pub-id><pub-id pub-id-type="pmcid">PMC5380334</pub-id></mixed-citation></ref><ref id="pone.0274276.ref070"><label>70</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Roy</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>WF</given-names></name>. <article-title>Prediction modeling using EHR data: Challenges, strategies, and a comparison of machine learning approaches</article-title>. <source>Med Care</source>. <year>2010</year>;<volume>48</volume>: <fpage>S106</fpage>&#8211;<lpage>S113</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/MLR.0b013e3181de9e17</pub-id><pub-id pub-id-type="pmid">20473190</pub-id></mixed-citation></ref><ref id="pone.0274276.ref071"><label>71</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Waljee</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Lipson</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wiitala</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning</article-title>. <source>Inflamm Bowel Dis</source>. <year>2018</year>;<volume>24</volume>: <fpage>45</fpage>&#8211;<lpage>53</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ibd/izx007</pub-id><pub-id pub-id-type="pmid">29272474</pub-id><pub-id pub-id-type="pmcid">PMC5931801</pub-id></mixed-citation></ref><ref id="pone.0274276.ref072"><label>72</label><mixed-citation publication-type="journal"><name name-style="western"><surname>&#193;lvarez-Guisasola</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Conget</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Franch</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mata</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mediavilla</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Sarria</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Adding questions about cardiovascular risk factors improve the ability of the ADA questionnaire to identify unknown diabetic patients in Spain</article-title>. <source>Diabetologia</source>. <year>2010</year>;<volume>26</volume>: <fpage>347</fpage>&#8211;<lpage>352</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S1134-3230(10)65008-9</pub-id></mixed-citation></ref><ref id="pone.0274276.ref073"><label>73</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Crutzen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Belur Nagaraj</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Taxis</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Denig</surname><given-names>P</given-names></name>. <article-title>Identifying patients at increased risk of hypoglycaemia in primary care: Development of a machine learning-based screening tool</article-title>. <source>Diabetes Metab Res Rev</source>. <year>2021</year>;<volume>37</volume>: <fpage>e3426</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/dmrr.3426</pub-id><pub-id pub-id-type="pmid">33289318</pub-id><pub-id pub-id-type="pmcid">PMC8518928</pub-id></mixed-citation></ref><ref id="pone.0274276.ref074"><label>74</label><mixed-citation publication-type="other">Ding X, Ajmal I, Trerotola OSc, Fraker D, Cohen J, Wachtel H, et al. EHR-based modeling specifically identifies patients with primary aldosteronism. In: Circulation [Internet]. 2019 [cited 22 Sep 2021]. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;D=emed20&amp;AN=630921513" ext-link-type="uri">https://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;D=emed20&amp;AN=630921513</ext-link></mixed-citation></ref><ref id="pone.0274276.ref075"><label>75</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dugan</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Mukhopadhyay</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Carroll</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Downs</surname><given-names>S</given-names></name>. <article-title>Machine learning techniques for prediction of early childhood obesity</article-title>. <source>Appl Clin Inform</source>. <year>2015</year>;<volume>6</volume>: <fpage>506</fpage>&#8211;<lpage>520</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4338/ACI-2015-03-RA-0036</pub-id><pub-id pub-id-type="pmid">26448795</pub-id><pub-id pub-id-type="pmcid">PMC4586339</pub-id></mixed-citation></ref><ref id="pone.0274276.ref076"><label>76</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Farran</surname><given-names>B</given-names></name>, <name name-style="western"><surname>AlWotayan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Alkandari</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Al-Abdulrazzaq</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Channanath</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Thanaraj</surname><given-names>TA</given-names></name>. <article-title>Use of Non-invasive Parameters and Machine-Learning Algorithms for Predicting Future Risk of Type 2 Diabetes: A Retrospective Cohort Study of Health Data From Kuwait</article-title>. <source>Front Endocrinol (Lausanne)</source>. <year>2019</year>;<volume>10</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fendo.2019.00624</pub-id><pub-id pub-id-type="pmid">31572303</pub-id><pub-id pub-id-type="pmcid">PMC6749017</pub-id></mixed-citation></ref><ref id="pone.0274276.ref077"><label>77</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hammond</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Athanasiadou</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Curado</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Aphinyanaphongs</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Abrams</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Messito</surname><given-names>MJ</given-names></name>, <etal>et al</etal>. <article-title>Predicting childhood obesity using electronic health records and publicly available data</article-title>. <source>PLoS One</source>. <year>2019</year>;<volume>14</volume>: <fpage>e0215571</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0215571</pub-id><pub-id pub-id-type="pmid">31009509</pub-id><pub-id pub-id-type="pmcid">PMC6476510</pub-id></mixed-citation></ref><ref id="pone.0274276.ref078"><label>78</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kopitar</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kocbek</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Cilar</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sheikh</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Stiglic</surname><given-names>G</given-names></name>. <article-title>Early detection of type 2 diabetes mellitus using machine learning-based prediction models</article-title>. <source>Sci Rep</source>. <year>2020</year>;<volume>10</volume>: <fpage>11981</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-020-68771-z</pub-id><pub-id pub-id-type="pmid">32686721</pub-id><pub-id pub-id-type="pmcid">PMC7371679</pub-id></mixed-citation></ref><ref id="pone.0274276.ref079"><label>79</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lethebe</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Williamson</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Garies</surname><given-names>S</given-names></name>, <name name-style="western"><surname>McBrien</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Leduc</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Butalia</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Developing a case definition for type 1 diabetes mellitus in a primary care electronic medical record database: an exploratory study</article-title>. <source>C open</source>. <year>2019</year>;<volume>7</volume>: <fpage>E246</fpage>&#8211;<lpage>E251</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.9778/cmajo.20180142</pub-id><pub-id pub-id-type="pmid">31061005</pub-id><pub-id pub-id-type="pmcid">PMC6504632</pub-id></mixed-citation></ref><ref id="pone.0274276.ref080"><label>80</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Looker</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Colombo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hess</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Brosnan</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Farran</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Dalton</surname><given-names>RN</given-names></name>, <etal>et al</etal>. <article-title>Biomarkers of rapid chronic kidney disease progression in type 2 diabetes</article-title>. <source>Kidney Int</source>. <year>2015</year>;<volume>88</volume>: <fpage>888</fpage>&#8211;<lpage>896</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ki.2015.199</pub-id><pub-id pub-id-type="pmid">26200946</pub-id></mixed-citation></ref><ref id="pone.0274276.ref081"><label>81</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Metsker</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Magoev</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yanishevskiy</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yakovlev</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kopanitsa</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Zvartau</surname><given-names>N</given-names></name>. <article-title>Identification of diabetes risk factors in chronic cardiovascular patients</article-title>. <source>Stud Health Technol Inform</source>. <year>2020</year>;<volume>273</volume>: <fpage>136</fpage>&#8211;<lpage>141</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3233/SHTI200628</pub-id><pub-id pub-id-type="pmid">33087603</pub-id></mixed-citation></ref><ref id="pone.0274276.ref082"><label>82</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Metzker</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Magoev</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yanishevskiy</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yakovlev</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kopanitsa</surname><given-names>G</given-names></name>. <article-title>Risk factors for chronic diabetes patients</article-title>. <source>Stud Health Technol Inform</source>. <year>2020</year>;<volume>270</volume>: <fpage>1379</fpage>&#8211;<lpage>1380</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3233/SHTI200451</pub-id><pub-id pub-id-type="pmid">32570668</pub-id></mixed-citation></ref><ref id="pone.0274276.ref083"><label>83</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nagaraj</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Sidorenkov</surname><given-names>G</given-names></name>, <name name-style="western"><surname>van Boven</surname><given-names>JFM</given-names></name>, <name name-style="western"><surname>Denig</surname><given-names>P</given-names></name>. <article-title>Predicting short- and long-term glycated haemoglobin response after insulin initiation in patients with type 2 diabetes mellitus using machine-learning algorithms</article-title>. <source>Diabetes, Obes Metab</source>. <year>2019</year>;<volume>21</volume>: <fpage>2704</fpage>&#8211;<lpage>2711</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/dom.13860</pub-id><pub-id pub-id-type="pmid">31453664</pub-id><pub-id pub-id-type="pmcid">PMC6899933</pub-id></mixed-citation></ref><ref id="pone.0274276.ref084"><label>84</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Rumora</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Alakwaa</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Andersen</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Reynolds</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>J&#248;rgensen</surname><given-names>ME</given-names></name>, <etal>et al</etal>. <article-title>Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes</article-title>. <source>Ann Clin Transl Neurol</source>. <year>2021</year>;<volume>8</volume>: <fpage>1292</fpage>&#8211;<lpage>1307</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/acn3.51367</pub-id><pub-id pub-id-type="pmid">33955722</pub-id><pub-id pub-id-type="pmcid">PMC8164865</pub-id></mixed-citation></ref><ref id="pone.0274276.ref085"><label>85</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lv</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>An early model to predict the risk of gestational diabetes mellitus in the absence of blood examination indexes: application in primary health care centres</article-title>. <source>BMC Pregnancy Childbirth</source>. <year>2021</year>;<volume>21</volume>: <fpage>814</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12884-021-04295-2</pub-id><pub-id pub-id-type="pmid">34879850</pub-id><pub-id pub-id-type="pmcid">PMC8653559</pub-id></mixed-citation></ref><ref id="pone.0274276.ref086"><label>86</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Williamson</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wojcik</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Taunton</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McElheran</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Howard</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Staszak</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Finding Undiagnosed Patients With Familial Hypercholesterolemia in Primary Care Usingelectronic Health Records</article-title>. <source>J Am Coll Cardiol</source>. <year>2020</year>;<volume>75</volume>: <fpage>3502</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0735-1097(20)34129-2</pub-id></mixed-citation></ref><ref id="pone.0274276.ref087"><label>87</label><mixed-citation publication-type="journal"><name name-style="western"><surname>DelPozo-Banos</surname><given-names>M</given-names></name>, <name name-style="western"><surname>John</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Petkov</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Berridge</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Southern</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Loyd</surname><given-names>KL</given-names></name>, <etal>et al</etal>. <article-title>Using neural networks with routine health records to identify suicide risk: Feasibility study</article-title>. <source>JMIR Ment Heal</source>. <year>2018</year>;<volume>5</volume>: <fpage>e10144</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2196/10144</pub-id><pub-id pub-id-type="pmid">29934287</pub-id><pub-id pub-id-type="pmcid">PMC6035342</pub-id></mixed-citation></ref><ref id="pone.0274276.ref088"><label>88</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Penfold</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Shortreed</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Ziebell</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>FL</given-names></name>, <name name-style="western"><surname>Clarke</surname><given-names>GN</given-names></name>, <etal>et al</etal>. <article-title>Predicting suicide attempts and suicide deaths among adolescents following outpatient visits</article-title>. <source>J Affect Disord</source>. <year>2021</year>;<volume>294</volume>: <fpage>39</fpage>&#8211;<lpage>47</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jad.2021.06.057</pub-id><pub-id pub-id-type="pmid">34265670</pub-id><pub-id pub-id-type="pmcid">PMC8820270</pub-id></mixed-citation></ref><ref id="pone.0274276.ref089"><label>89</label><mixed-citation publication-type="journal"><name name-style="western"><surname>van Mens</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Elzinga</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Nielen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lokkerbol</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Poortvliet</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Donker</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Applying machine learning on health record data from general practitioners to predict suicidality</article-title>. <source>Internet Interv</source>. <year>2020</year>;<volume>21</volume>: <fpage>100337</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.invent.2020.100337</pub-id><pub-id pub-id-type="pmid">32944503</pub-id><pub-id pub-id-type="pmcid">PMC7481555</pub-id></mixed-citation></ref><ref id="pone.0274276.ref090"><label>90</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shih</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>G Den</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>CC</given-names></name>. <article-title>Risk prediction for early chronic kidney disease: Results from an adult health examination program of 19,270 individuals</article-title>. <source>Int J Environ Res Public Health</source>. <year>2020</year>;<volume>17</volume>: <fpage>1</fpage>&#8211;<lpage>11</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/ijerph17144973</pub-id><pub-id pub-id-type="pmid">32664271</pub-id><pub-id pub-id-type="pmcid">PMC7399976</pub-id></mixed-citation></ref><ref id="pone.0274276.ref091"><label>91</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>McDermaid</surname><given-names>A</given-names></name>. <article-title>Predicting outcomes of chronic kidney disease from EMR data based on Random Forest Regression</article-title>. <source>Math Biosci</source>. <year>2019</year>;<volume>310</volume>: <fpage>24</fpage>&#8211;<lpage>30</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.mbs.2019.02.001</pub-id><pub-id pub-id-type="pmid">30768948</pub-id><pub-id pub-id-type="pmcid">PMC6435377</pub-id></mixed-citation></ref><ref id="pone.0274276.ref092"><label>92</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dinga</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Marquand</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Veltman</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Beekman</surname><given-names>ATF</given-names></name>, <name name-style="western"><surname>Schoevers</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>van Hemert</surname><given-names>AM</given-names></name>, <etal>et al</etal>. <article-title>Predicting the naturalistic course of depression from a wide range of clinical, psychological, and biological data: a machine learning approach</article-title>. <source>Transl Psychiatry</source>. <year>2018</year>;<volume>8</volume>: <fpage>241</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41398-018-0289-1</pub-id><pub-id pub-id-type="pmid">30397196</pub-id><pub-id pub-id-type="pmcid">PMC6218451</pub-id></mixed-citation></ref><ref id="pone.0274276.ref093"><label>93</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ford</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Rooney</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Oliver</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hoile</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hurley</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Banerjee</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Identifying undetected dementia in UK primary care patients: A retrospective case-control study comparing machine-learning and standard epidemiological approaches</article-title>. <source>BMC Med Inform Decis Mak</source>. <year>2019</year>;<volume>19</volume>: <fpage>248</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12911-019-0991-9</pub-id><pub-id pub-id-type="pmid">31791325</pub-id><pub-id pub-id-type="pmcid">PMC6889642</pub-id></mixed-citation></ref><ref id="pone.0274276.ref094"><label>94</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ford</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Starlinger</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rooney</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Oliver</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Banerjee</surname><given-names>S</given-names></name>, <name name-style="western"><surname>van Marwijk</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Could dementia be detected from UK primary care patients&#8217; records by simple automated methods earlier than by the treating physician? A retrospective case-control study</article-title>. <source>Wellcome Open Res</source>. <year>2020</year>;<volume>5</volume>: <fpage>120</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.12688/wellcomeopenres.15903.1</pub-id><pub-id pub-id-type="pmid">32766457</pub-id><pub-id pub-id-type="pmcid">PMC7385545</pub-id></mixed-citation></ref><ref id="pone.0274276.ref095"><label>95</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ford</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sheppard</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Oliver</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rooney</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Banerjee</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cassell</surname><given-names>JA</given-names></name>. <article-title>Automated detection of patients with dementia whose symptoms have been identified in primary care but have no formal diagnosis: A retrospective case-control study using electronic primary care records</article-title>. <source>BMJ Open</source>. <year>2021</year>;<volume>11</volume>: <fpage>e039248</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmjopen-2020-039248</pub-id><pub-id pub-id-type="pmid">33483436</pub-id><pub-id pub-id-type="pmcid">PMC7831719</pub-id></mixed-citation></ref><ref id="pone.0274276.ref096"><label>96</label><mixed-citation publication-type="other">Fouladvand S, Mielke MM, Vassilaki M, St. Sauver J, Petersen RC, Sohn S. Deep Learning Prediction of Mild Cognitive Impairment using Electronic Health Records. 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE; 2019. pp. 799&#8211;806.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1109/bibm47256.2019.8982955</pub-id><pub-id pub-id-type="pmcid">PMC7665163</pub-id><pub-id pub-id-type="pmid">33194303</pub-id></mixed-citation></ref><ref id="pone.0274276.ref097"><label>97</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Haun</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Simon</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sklenarova</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zimmermann-Schlegel</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Friederich</surname><given-names>H-CHC</given-names></name>, <name name-style="western"><surname>Hartmann</surname><given-names>M</given-names></name>. <article-title>Predicting anxiety in cancer survivors presenting to primary care&#8211;A machine learning approach accounting for physical comorbidity</article-title>. <source>Cancer Med</source>. <year>2021</year>;<volume>10</volume>: <fpage>5001</fpage>&#8211;<lpage>5016</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/cam4.4048</pub-id><pub-id pub-id-type="pmid">34076372</pub-id><pub-id pub-id-type="pmcid">PMC8290227</pub-id></mixed-citation></ref><ref id="pone.0274276.ref098"><label>98</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jammeh</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Carroll</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Pearson Stephen</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Escudero</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Anastasiou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Machine-learning based identification of undiagnosed dementia in primary care: A feasibility study</article-title>. <source>BJGP Open</source>. <year>2018</year>;<volume>2</volume>: <comment>doi: </comment><pub-id pub-id-type="doi">10.3399/bjgpopen18X101589</pub-id><pub-id pub-id-type="pmid">30564722</pub-id><pub-id pub-id-type="pmcid">PMC6184101</pub-id></mixed-citation></ref><ref id="pone.0274276.ref099"><label>99</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jin</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>S</given-names></name>. <article-title>Use of patient-reported data to match depression screening intervals with depression risk profiles in primary care patients with diabetes: Development and validation of prediction models for major depression</article-title>. <source>JMIR Form Res</source>. <year>2019</year>;<volume>3</volume>: <fpage>e13610</fpage>&#8211;<lpage>e13610</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2196/13610</pub-id><pub-id pub-id-type="pmid">31573900</pub-id><pub-id pub-id-type="pmcid">PMC6774232</pub-id></mixed-citation></ref><ref id="pone.0274276.ref100"><label>100</label><mixed-citation publication-type="other">Kaczmarek E, Salgo A, Zafari H, Kosowan L, Singer A, Zulkernine F. Diagnosing PTSD using electronic medical records from Canadian primary care data. ACM International Conference Proceeding Series. School of Computing, Queen&#8217;s University, Kingston, Canada; 2019. pp. 23&#8211;29.</mixed-citation></ref><ref id="pone.0274276.ref101"><label>101</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ljubic</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Roychoudhury</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>XH</given-names></name>, <name name-style="western"><surname>Pavlovski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Obradovic</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nair</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Influence of medical domain knowledge on deep learning for Alzheimer&#8217;s disease prediction</article-title>. <source>Comput Methods Programs Biomed</source>. <year>2020</year>;<volume>197</volume>: <fpage>105765</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cmpb.2020.105765</pub-id><pub-id pub-id-type="pmid">33011665</pub-id><pub-id pub-id-type="pmcid">PMC7502243</pub-id></mixed-citation></ref><ref id="pone.0274276.ref102"><label>102</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mallo</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Valladares-Rodriguez</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Facal</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Lojo-Seoane</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fern&#225;ndez-Iglesias</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Pereiro</surname><given-names>AX</given-names></name>. <article-title>Neuropsychiatric symptoms as predictors of conversion from MCI to dementia: A machine learning approach</article-title>. <source>Int Psychogeriatrics</source>. <year>2020</year>;<volume>32</volume>: <fpage>381</fpage>&#8211;<lpage>392</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1017/S1041610219001030</pub-id><pub-id pub-id-type="pmid">31455461</pub-id></mixed-citation></ref><ref id="pone.0274276.ref103"><label>103</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mar</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gorostiza</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ibarrondo</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Cernuda</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Arrospide</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Iruin</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Validation of Random Forest Machine Learning Models to Predict Dementia-Related Neuropsychiatric Symptoms in Real-World Data</article-title>. <source>J Alzheimer&#8217;s Dis</source>. <year>2020</year>;<volume>77</volume>: <fpage>855</fpage>&#8211;<lpage>864</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3233/JAD-200345</pub-id><pub-id pub-id-type="pmid">32741825</pub-id><pub-id pub-id-type="pmcid">PMC7592688</pub-id></mixed-citation></ref><ref id="pone.0274276.ref104"><label>104</label><mixed-citation publication-type="journal"><name name-style="western"><surname>P&#243;&#322;ch&#322;opek</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Koning</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>B&#252;chner</surname><given-names>FL</given-names></name>, <name name-style="western"><surname>Crone</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Numans</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Hoogendoorn</surname><given-names>M</given-names></name>. <article-title>Quantitative and temporal approach to utilising electronic medical records from general practices in mental health prediction</article-title>. <source>Comput Biol Med</source>. <year>2020</year>;<fpage>125</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.compbiomed.2020.103973</pub-id><pub-id pub-id-type="pmid">32916386</pub-id></mixed-citation></ref><ref id="pone.0274276.ref105"><label>105</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rick Yiu-Cho</surname><given-names>Kwan</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>KS</given-names></name>. <article-title>Using dual neural network architecture to detect the risk of dementia with community health data: Algorithm development and validation study</article-title>. <source>JMIR Med Informatics</source>. <year>2020</year>;<volume>8</volume>: <fpage>e19870</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2196/19870</pub-id><pub-id pub-id-type="pmid">32865498</pub-id><pub-id pub-id-type="pmcid">PMC7490674</pub-id></mixed-citation></ref><ref id="pone.0274276.ref106"><label>106</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Su&#225;rez-Araujo</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Garc&#237;a B&#225;ez</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Cabrera-Le&#243;n</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Prochazka</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rodr&#237;guez Espinosa</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Fern&#225;ndez Viadero</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>A Real-Time Clinical Decision Support System, for Mild Cognitive Impairment Detection, Based on a Hybrid Neural Architecture</article-title>. <name name-style="western"><surname>Bangyal</surname><given-names>WH</given-names></name>, editor. <source>Comput Math Methods Med</source>. <year>2021</year>;<volume>2021</volume>: <fpage>1</fpage>&#8211;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1155/2021/5545297</pub-id><pub-id pub-id-type="pmid">34257699</pub-id><pub-id pub-id-type="pmcid">PMC8257364</pub-id></mixed-citation></ref><ref id="pone.0274276.ref107"><label>107</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zafari</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kosowan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zulkernine</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Signer</surname><given-names>A</given-names></name>. <article-title>Diagnosing post-traumatic stress disorder using electronic medical record data</article-title>. <source>Health Informatics J</source>. <year>2021</year>;<volume>27</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/14604582211053259</pub-id><pub-id pub-id-type="pmid">34818936</pub-id></mixed-citation></ref><ref id="pone.0274276.ref108"><label>108</label><mixed-citation publication-type="other">Emir B, Mardekian J, Masters ET, Clair A, Kuhn M, Silverman SL. Predictive modeling of a fibromyalgia diagnosis: Increasing the accuracy using real world data. Meeting: 2014 ACR/ARHP Annual Meeting. ACR; 2014.</mixed-citation></ref><ref id="pone.0274276.ref109"><label>109</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jarvik</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Gold</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Friedly</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Nedeljkovic</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Comstock</surname><given-names>BA</given-names></name>, <etal>et al</etal>. <article-title>Long-term outcomes of a large, prospective observational cohort of older adults with back pain</article-title>. <source>Spine J</source>. <year>2018</year>;<volume>18</volume>: <fpage>1540</fpage>&#8211;<lpage>1551</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.spinee.2018.01.018</pub-id><pub-id pub-id-type="pmid">29391206</pub-id></mixed-citation></ref><ref id="pone.0274276.ref110"><label>110</label><mixed-citation publication-type="other">Kennedy J, Kennedy N, Cooksey R, Choy E, Siebert S, Rahman M, et al. Predicting a diagnosis of ankylosing spondylitis using primary care health records&#8211;a machine learning approach. medRxiv. 2021; 2021.04.22.21255659.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0279076</pub-id><pub-id pub-id-type="pmcid">PMC10065228</pub-id><pub-id pub-id-type="pmid">37000839</pub-id></mixed-citation></ref><ref id="pone.0274276.ref111"><label>111</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kop</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hoogendoorn</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Teije</surname><given-names>A ten</given-names></name>, <name name-style="western"><surname>B&#252;chner</surname><given-names>FL</given-names></name>, <name name-style="western"><surname>Slottje</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Moons</surname><given-names>LMG</given-names></name>, <etal>et al</etal>. <article-title>Predictive modeling of colorectal cancer using a dedicated pre-processing pipeline on routine electronic medical records</article-title>. <source>Comput Biol Med</source>. <year>2016</year>;<volume>76</volume>: <fpage>30</fpage>&#8211;<lpage>38</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.compbiomed.2016.06.019</pub-id><pub-id pub-id-type="pmid">27392227</pub-id></mixed-citation></ref><ref id="pone.0274276.ref112"><label>112</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Malhotra</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rachet</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bonaventure</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pereira</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Woods</surname><given-names>LM</given-names></name>. <article-title>Can we screen for pancreatic cancer? Identifying a sub-population of patients at high risk of subsequent diagnosis using machine learning techniques applied to primary care data</article-title>. <source>PLoS One</source>. <year>2021</year>;<volume>16</volume>: <fpage>e0251876</fpage>&#8211;<lpage>e0251876</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0251876</pub-id><pub-id pub-id-type="pmid">34077433</pub-id><pub-id pub-id-type="pmcid">PMC8171946</pub-id></mixed-citation></ref><ref id="pone.0274276.ref113"><label>113</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ristanoski</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Emery</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gutierrez</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>McCarthy</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Aickelin</surname><given-names>U</given-names></name>. <article-title>Primary Care Datasets for Early Lung Cancer Detection: An AI Led Approach</article-title>. <source>Lecture Notes in Computer Science. AIME</source>; <year>2021</year>. pp. <fpage>83</fpage>&#8211;<lpage>92</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/978-3-030-77211-6_9</pub-id></mixed-citation></ref><ref id="pone.0274276.ref114"><label>114</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cox</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Raluy</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bakheit</surname><given-names>AMO</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Dinet</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Predictive analysis for identifying post stroke spasticity patients in UK primary care data</article-title>. <source>Pharmacoepidemiol Drug Saf</source>. <year>2014</year>;<volume>23</volume>: <fpage>422</fpage>&#8211;<lpage>423</lpage>.</mixed-citation></ref><ref id="pone.0274276.ref115"><label>115</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hrabok</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Engbers</surname><given-names>JDT</given-names></name>, <name name-style="western"><surname>Wiebe</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sajobi</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Subota</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Almohawes</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Primary care electronic medical records can be used to predict risk and identify potentially modifiable factors for early and late death in adult onset epilepsy</article-title>. <source>Epilepsia</source>. <year>2021</year>;<volume>62</volume>: <fpage>51</fpage>&#8211;<lpage>60</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/epi.16738</pub-id><pub-id pub-id-type="pmid">33316095</pub-id></mixed-citation></ref><ref id="pone.0274276.ref116"><label>116</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kwasny</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Oleske</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Zamudio</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Diegidio</surname><given-names>R</given-names></name>, <name name-style="western"><surname>H&#246;glinger</surname><given-names>GU</given-names></name>. <article-title>Clinical Features Observed in General Practice Associated With the Subsequent Diagnosis of Progressive Supranuclear Palsy</article-title>. <source>Front Neurol</source>. <year>2021</year>;<volume>12</volume>: <fpage>637176</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fneur.2021.637176</pub-id><pub-id pub-id-type="pmid">33967937</pub-id><pub-id pub-id-type="pmcid">PMC8100604</pub-id></mixed-citation></ref><ref id="pone.0274276.ref117"><label>117</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Afzal</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Engelkes</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Verhamme</surname><given-names>KMC</given-names></name>, <name name-style="western"><surname>Janssens</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Sturkenboom</surname><given-names>MCJM</given-names></name>, <name name-style="western"><surname>Kors</surname><given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Automatic generation of case-detection algorithms to identify children with asthma from large electronic health record databases</article-title>. <source>Pharmacoepidemiol Drug Saf</source>. <year>2013</year>;<volume>22</volume>: <fpage>826</fpage>&#8211;<lpage>833</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/pds.3438</pub-id><pub-id pub-id-type="pmid">23592573</pub-id></mixed-citation></ref><ref id="pone.0274276.ref118"><label>118</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Doyle</surname><given-names>OM</given-names></name>, <name name-style="western"><surname>van der Laan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Obradovic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McMahon</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Daniels</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Pitcher</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Identification of potentially undiagnosed patients with nontuberculous mycobacterial lung disease using machine learning applied to primary care data in the UK</article-title>. <source>Eur Respir J</source>. 2020/05/21. <year>2020</year>;<volume>56</volume>: <fpage>2000045</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1183/13993003.00045-2020</pub-id><pub-id pub-id-type="pmid">32430411</pub-id></mixed-citation></ref><ref id="pone.0274276.ref119"><label>119</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Weisman</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Austin</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Jaakkimainen</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Validation of a type 1 diabetes algorithm using electronic medical records and administrative healthcare data to study the population incidence and prevalence of type 1 diabetes in Ontario, Canada</article-title>. <source>BMJ Open Diabetes Res Care</source>. <year>2020</year>;<volume>8</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmjdrc-2020-001224</pub-id><pub-id pub-id-type="pmid">32565422</pub-id><pub-id pub-id-type="pmcid">PMC7307536</pub-id></mixed-citation></ref><ref id="pone.0274276.ref120"><label>120</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Amit</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Girshovitz</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Marcus</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Pathak</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bar</surname><given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Estimation of postpartum depression risk from electronic health records using machine learning</article-title>. <source>BMC Pregnancy Childbirth</source>. <year>2021</year>;<volume>21</volume>: <fpage>630</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12884-021-04087-8</pub-id><pub-id pub-id-type="pmid">34535116</pub-id><pub-id pub-id-type="pmcid">PMC8447665</pub-id></mixed-citation></ref><ref id="pone.0274276.ref121"><label>121</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Perlis</surname><given-names>RH</given-names></name>. <article-title>A clinical risk stratification tool for predicting treatment resistance in major depressive disorder</article-title>. <source>Biol Psychiatry</source>. <year>2013</year>;<volume>74</volume>: <fpage>7</fpage>&#8211;<lpage>14</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.biopsych.2012.12.007</pub-id><pub-id pub-id-type="pmid">23380715</pub-id><pub-id pub-id-type="pmcid">PMC3690142</pub-id></mixed-citation></ref><ref id="pone.0274276.ref122"><label>122</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Fern&#225;ndez-Guti&#233;rrez</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>JI</given-names></name>, <name name-style="western"><surname>Cooksey</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Atkinson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Choy</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Brophy</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Mining Primary Care Electronic Health Records for Automatic Disease Phenotyping: A Transparent Machine Learning Framework</article-title>. <source>Diagnostics</source>. <year>2021</year>;<volume>11</volume>: <fpage>1908</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/diagnostics11101908</pub-id><pub-id pub-id-type="pmid">34679609</pub-id><pub-id pub-id-type="pmcid">PMC8534858</pub-id></mixed-citation></ref><ref id="pone.0274276.ref123"><label>123</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jorge</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Castro</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Barnado</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gainer</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Identifying lupus patients in electronic health records: Development and validation of machine learning algorithms and application of rule-based algorithms</article-title>. <source>Semin Arthritis Rheum</source>. <year>2019</year>;<volume>49</volume>: <fpage>84</fpage>&#8211;<lpage>90</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.semarthrit.2019.01.002</pub-id><pub-id pub-id-type="pmid">30665626</pub-id><pub-id pub-id-type="pmcid">PMC6609504</pub-id></mixed-citation></ref><ref id="pone.0274276.ref124"><label>124</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhou</surname><given-names>S-M</given-names></name>, <name name-style="western"><surname>Fernandez-Gutierrez</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cooksey</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Atkinson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Denaxas</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Defining Disease Phenotypes in Primary Care Electronic Health Records by a Machine Learning Approach: A Case Study in Identifying Rheumatoid Arthritis</article-title>. <name name-style="western"><surname>Pappalardo</surname><given-names>F</given-names></name>, editor. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>: <fpage>e0154515</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0154515</pub-id><pub-id pub-id-type="pmid">27135409</pub-id><pub-id pub-id-type="pmcid">PMC4852928</pub-id></mixed-citation></ref><ref id="pone.0274276.ref125"><label>125</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kinar</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kalkstein</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Akiva</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Levin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Half</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Goldshtein</surname><given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: A binational retrospective study</article-title>. <source>J Am Med Informatics Assoc</source>. <year>2016</year>;<volume>23</volume>: <fpage>879</fpage>&#8211;<lpage>890</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/jamia/ocv195</pub-id><pub-id pub-id-type="pmid">26911814</pub-id><pub-id pub-id-type="pmcid">PMC4997037</pub-id></mixed-citation></ref><ref id="pone.0274276.ref126"><label>126</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sufriyana</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>YW</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>ECY</given-names></name>. <article-title>Artificial intelligence-assisted prediction of preeclampsia: Development and external validation of a nationwide health insurance dataset of the BPJS Kesehatan in Indonesia</article-title>. <source>EBioMedicine</source>. <year>2020</year>;<volume>54</volume>: <fpage>102710</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ebiom.2020.102710</pub-id><pub-id pub-id-type="pmid">32283530</pub-id><pub-id pub-id-type="pmcid">PMC7152721</pub-id></mixed-citation></ref><ref id="pone.0274276.ref127"><label>127</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Abr&#224;moff</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Lavin</surname><given-names>PT</given-names></name>, <name name-style="western"><surname>Birch</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Folk</surname><given-names>JC</given-names></name>. <article-title>Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices</article-title>. <source>NPJ Digit Med</source>. 2019/07/16. <year>2018</year>;<volume>1</volume>: <fpage>39</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41746-018-0040-6</pub-id><pub-id pub-id-type="pmid">31304320</pub-id><pub-id pub-id-type="pmcid">PMC6550188</pub-id></mixed-citation></ref><ref id="pone.0274276.ref128"><label>128</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bhaskaranand</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ramachandra</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bhat</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cuadros</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Nittala</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Sadda</surname><given-names>SR</given-names></name>, <etal>et al</etal>. <article-title>The value of automated diabetic retinopathy screening with the EyeArt system: A study of more than 100,000 consecutive encounters from people with diabetes</article-title>. <source>Diabetes Technol Ther</source>. <year>2019</year>;<volume>21</volume>: <fpage>635</fpage>&#8211;<lpage>643</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1089/dia.2019.0164</pub-id><pub-id pub-id-type="pmid">31335200</pub-id><pub-id pub-id-type="pmcid">PMC6812728</pub-id></mixed-citation></ref><ref id="pone.0274276.ref129"><label>129</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gonz&#225;lez-Gonzalo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>S&#225;nchez-Guti&#233;rrez</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Hern&#225;ndez-Mart&#237;nez</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Contreras</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Lechanteur</surname><given-names>YT</given-names></name>, <name name-style="western"><surname>Domanian</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Evaluation of a deep learning system for the joint automated detection of diabetic retinopathy and age-related macular degeneration</article-title>. <source>Acta Ophthalmol</source>. <year>2020</year>;<volume>98</volume>: <fpage>368</fpage>&#8211;<lpage>377</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/aos.14306</pub-id><pub-id pub-id-type="pmid">31773912</pub-id><pub-id pub-id-type="pmcid">PMC7318689</pub-id></mixed-citation></ref><ref id="pone.0274276.ref130"><label>130</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kanagasingam</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Vignarajan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Preetham</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tay-Kearney</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Mehrotra</surname><given-names>A</given-names></name>. <article-title>Evaluation of Artificial Intelligence-Based Grading of Diabetic Retinopathy in Primary Care</article-title>. <source>JAMA Netw open</source>. <year>2018</year>;<volume>1</volume>: <fpage>e182665</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2018.2665</pub-id><pub-id pub-id-type="pmid">30646178</pub-id><pub-id pub-id-type="pmcid">PMC6324474</pub-id></mixed-citation></ref><ref id="pone.0274276.ref131"><label>131</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hoogendoorn</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Szolovits</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Moons</surname><given-names>LMG</given-names></name>, <name name-style="western"><surname>Numans</surname><given-names>ME</given-names></name>. <article-title>Utilizing uncoded consultation notes from electronic medical records for predictive modeling of colorectal cancer</article-title>. <source>Artif Intell Med</source>. <year>2016</year>;<volume>69</volume>: <fpage>53</fpage>&#8211;<lpage>61</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.artmed.2016.03.003</pub-id><pub-id pub-id-type="pmid">27085847</pub-id><pub-id pub-id-type="pmcid">PMC4884499</pub-id></mixed-citation></ref><ref id="pone.0274276.ref132"><label>132</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Morales</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Flynn</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Trucco</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Quint</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Zutis</surname><given-names>K</given-names></name>. <article-title>External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches</article-title>. <source>Respir Med</source>. <year>2018</year>;<volume>138</volume>: <fpage>150</fpage>&#8211;<lpage>155</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.rmed.2018.04.003</pub-id><pub-id pub-id-type="pmid">29724388</pub-id></mixed-citation></ref><ref id="pone.0274276.ref133"><label>133</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Alexander</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Alexander</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Barkhof</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Denaxas</surname><given-names>S</given-names></name>. <article-title>Identifying and evaluating clinical subtypes of Alzheimer&#8217;s disease in care electronic health records using unsupervised machine learning</article-title>. <source>BMC Med Inform Decis Mak</source>. <year>2021</year>;<volume>21</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12911-021-01693-6</pub-id><pub-id pub-id-type="pmid">34879829</pub-id><pub-id pub-id-type="pmcid">PMC8653614</pub-id></mixed-citation></ref><ref id="pone.0274276.ref134"><label>134</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nikolaou</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Massaro</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Garn</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Fakhimi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stergioulas</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Price</surname><given-names>DB</given-names></name>. <article-title>Fast decliner phenotype of chronic obstructive pulmonary disease (COPD): Applying machine learning for predicting lung function loss</article-title>. <source>BMJ Open Respir Res</source>. <year>2021</year>;<fpage>8</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmjresp-2021-000980</pub-id><pub-id pub-id-type="pmid">34716217</pub-id><pub-id pub-id-type="pmcid">PMC8559126</pub-id></mixed-citation></ref><ref id="pone.0274276.ref135"><label>135</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Pikoula</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Quint</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Nissen</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hemingway</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Smeeth</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Denaxas</surname><given-names>S</given-names></name>. <article-title>Identifying clinically important COPD sub-types using data-driven approaches in primary care population based electronic health records</article-title>. <source>BMC Med Inform Decis Mak</source>. <year>2019</year>;<volume>19</volume>: <fpage>86</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12911-019-0805-0</pub-id><pub-id pub-id-type="pmid">30999919</pub-id><pub-id pub-id-type="pmcid">PMC6472089</pub-id></mixed-citation></ref><ref id="pone.0274276.ref136"><label>136</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Collins</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Reitsma</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Moons</surname><given-names>KGMM</given-names></name>. <article-title>Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement</article-title>. <source>Ann Intern Med</source>. <year>2015</year>;<volume>162</volume>: <fpage>55</fpage>&#8211;<lpage>63</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.7326/M14-0697</pub-id><pub-id pub-id-type="pmid">25560714</pub-id></mixed-citation></ref><ref id="pone.0274276.ref137"><label>137</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nickel</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Barratt</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Copp</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Moynihan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>McCaffery</surname><given-names>K</given-names></name>. <article-title>Words do matter: a systematic review on how different terminology for the same condition influences management preferences</article-title>. <source>BMJ Open</source>. <year>2017</year>;<volume>7</volume>: <fpage>e014129</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmjopen-2016-014129</pub-id><pub-id pub-id-type="pmid">28698318</pub-id><pub-id pub-id-type="pmcid">PMC5541578</pub-id></mixed-citation></ref><ref id="pone.0274276.ref138"><label>138</label><mixed-citation publication-type="other">Ghassemi M, Naumann T, Schulam P, Beam AL, Chen IY, Ranganath R. A Review of Challenges and Opportunities in Machine Learning for Health. AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science American Medical Informatics Association; 2020 pp. 191&#8211;200.<pub-id pub-id-type="pmcid">PMC7233077</pub-id><pub-id pub-id-type="pmid">32477638</pub-id></mixed-citation></ref><ref id="pone.0274276.ref139"><label>139</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Fern&#225;ndez-Delgado</surname><given-names>Manuel</given-names></name>, <name name-style="western"><surname>Cernadas</surname><given-names>Eva</given-names></name>, <name name-style="western"><surname>Barro</surname><given-names>Sen&#233;n</given-names></name>, <name name-style="western"><surname>Amorim</surname><given-names>Dinani</given-names></name>. <article-title>Do we need hundreds of classifiers to solve real world classification problems?</article-title><source>J Mach Learn Res</source>. <year>2014</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.5555/2627435.2697065</pub-id></mixed-citation></ref><ref id="pone.0274276.ref140"><label>140</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Juarez-Orozco</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Martinez-Manzanera</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Nesterov S</surname><given-names>V</given-names></name>., <name name-style="western"><surname>Kajander</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Knuuti</surname><given-names>J</given-names></name>. <article-title>The machine learning horizon in cardiac hybrid imaging</article-title>. <source>Eur J Hybrid Imaging</source>. <year>2018</year>;<volume>2</volume>: <fpage>1</fpage>&#8211;<lpage>15</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/S41824-018-0033-3/FIGURES/5</pub-id>29782605</mixed-citation></ref><ref id="pone.0274276.ref141"><label>141</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Challen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Denny</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pitt</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gompels</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tsaneva-Atanasova</surname><given-names>K</given-names></name>. <article-title>Artificial intelligence, bias and clinical safety</article-title>. <source>BMJ Qual Saf</source>. <year>2019</year>;<volume>28</volume>: <fpage>231</fpage>&#8211;<lpage>237</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmjqs-2018-008370</pub-id><pub-id pub-id-type="pmid">30636200</pub-id><pub-id pub-id-type="pmcid">PMC6560460</pub-id></mixed-citation></ref><ref id="pone.0274276.ref142"><label>142</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name>. <article-title>Nonlinear systems in medicine</article-title>. <source>Yale J Biol Med</source>. <year>2002</year>;<volume>75</volume>: <fpage>247</fpage>&#8211;<lpage>260</lpage>. <pub-id pub-id-type="pmid">14580107</pub-id><pub-id pub-id-type="pmcid">PMC2588816</pub-id></mixed-citation></ref><ref id="pone.0274276.ref143"><label>143</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Decherchi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pedrini</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Mordenti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cavalli</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sangiorgi</surname><given-names>L</given-names></name>. <article-title>Opportunities and Challenges for Machine Learning in Rare Diseases</article-title>. <source>Front Med</source>. <year>2021</year>;<volume>8</volume>: <fpage>747612</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fmed.2021.747612</pub-id><pub-id pub-id-type="pmid">34676229</pub-id><pub-id pub-id-type="pmcid">PMC8523988</pub-id></mixed-citation></ref><ref id="pone.0274276.ref144"><label>144</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bozkurt</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cahan</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Seneviratne</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lossio-Ventura</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Ioannidis</surname><given-names>JPA</given-names></name>, <etal>et al</etal>. <article-title>Reporting of demographic data and representativeness in machine learning models using electronic health records</article-title>. <source>J Am Med Informatics Assoc</source>. <year>2020</year>;<volume>27</volume>: <fpage>1878</fpage>&#8211;<lpage>1884</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/jamia/ocaa164</pub-id><pub-id pub-id-type="pmid">32935131</pub-id><pub-id pub-id-type="pmcid">PMC7727384</pub-id></mixed-citation></ref><ref id="pone.0274276.ref145"><label>145</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Andaur Navarro</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Damen</surname><given-names>JAA</given-names></name>, <name name-style="western"><surname>Takada</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nijman</surname><given-names>SWJ</given-names></name>, <name name-style="western"><surname>Dhiman</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Completeness of reporting of clinical prediction models developed using supervised machine learning: a systematic review</article-title>. <source>BMC Med Res Methodol</source>. <year>2022</year>;<volume>22</volume>: <fpage>1</fpage>&#8211;<lpage>13</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/S12874-021-01469-6/FIGURES/3</pub-id><pub-id pub-id-type="pmid">35026997</pub-id><pub-id pub-id-type="pmcid">PMC8759172</pub-id></mixed-citation></ref><ref id="pone.0274276.ref146"><label>146</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kelly</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Karthikesalingam</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Suleyman</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Corrado</surname><given-names>G</given-names></name>, <name name-style="western"><surname>King</surname><given-names>D</given-names></name>. <article-title>Key challenges for delivering clinical impact with artificial intelligence</article-title>. <source>BMC Med</source>. <year>2019</year>;<volume>17</volume>: <fpage>195</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12916-019-1426-2</pub-id><pub-id pub-id-type="pmid">31665002</pub-id><pub-id pub-id-type="pmcid">PMC6821018</pub-id></mixed-citation></ref><ref id="pone.0274276.ref147"><label>147</label><mixed-citation publication-type="journal"><name name-style="western"><surname>El-Sherbini</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Hassan Virk</surname><given-names>HU</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Glicksberg</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Krittanawong</surname><given-names>C</given-names></name>. <article-title>Machine-Learning-Based Prediction Modelling in Primary Care: State-of-the-Art Review</article-title>. <source>Ai</source>. <year>2023</year>;<volume>4</volume>: <fpage>437</fpage>&#8211;<lpage>460</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/ai4020024</pub-id></mixed-citation></ref><ref id="pone.0274276.ref148"><label>148</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Luo</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Phung</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tran</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rana</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Karmakar</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Guidelines for developing and reporting machine learning predictive models in biomedical research: A multidisciplinary view</article-title>. <source>J Med Internet Res</source>. <year>2016</year>;<volume>18</volume>: <fpage>e5870</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2196/jmir.5870</pub-id><pub-id pub-id-type="pmid">27986644</pub-id><pub-id pub-id-type="pmcid">PMC5238707</pub-id></mixed-citation></ref><ref id="pone.0274276.ref149"><label>149</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Collins</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Moons</surname><given-names>KGMM</given-names></name>, <name name-style="western"><surname>GS Collins</surname><given-names>KM</given-names></name>. <article-title>Reporting of artificial intelligence prediction models</article-title>. <source>Lancet (London, England)</source>. <year>2019</year>;<volume>393</volume>: <fpage>1577</fpage>&#8211;<lpage>1579</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(19)30037-6</pub-id><pub-id pub-id-type="pmid">31007185</pub-id></mixed-citation></ref><ref id="pone.0274276.ref150"><label>150</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gentil</surname><given-names>M-L</given-names></name>, <name name-style="western"><surname>Cuggia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fiquet</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hagenbourger</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Le Berre</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ban&#226;tre</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Factors influencing the development of primary care data collection projects from electronic health records: A systematic review of the literature</article-title>. <source>BMC Med Inform Decis Mak</source>. <year>2017</year>;<volume>17</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12911-017-0538-x</pub-id><pub-id pub-id-type="pmid">28946908</pub-id><pub-id pub-id-type="pmcid">PMC5613384</pub-id></mixed-citation></ref><ref id="pone.0274276.ref151"><label>151</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cabitza</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Rasoini</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gensini</surname><given-names>GF</given-names></name>. <article-title>Unintended Consequences of Machine Learning in Medicine</article-title>. <source>JAMA</source>. <year>2017</year>;<volume>318</volume>: <fpage>517</fpage>&#8211;<lpage>518</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.2017.7797</pub-id><pub-id pub-id-type="pmid">28727867</pub-id></mixed-citation></ref><ref id="pone.0274276.ref152"><label>152</label><mixed-citation publication-type="journal"><name name-style="western"><surname>McDonald</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ramagopalan S</surname><given-names>V</given-names></name>., <name name-style="western"><surname>Cox</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Oguz</surname><given-names>M</given-names></name>. <article-title>Unintended consequences of machine learning in medicine?</article-title><source>F1000Research</source>. <year>2017</year>;<volume>6</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.12688/f1000research.12693.1</pub-id><pub-id pub-id-type="pmid">29250316</pub-id><pub-id pub-id-type="pmcid">PMC5701440</pub-id></mixed-citation></ref><ref id="pone.0274276.ref153"><label>153</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bakker</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Aarts</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Uyl-de Groot</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Redekop</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Groot</surname><given-names>CUD</given-names></name>, <name name-style="western"><surname>Redekop</surname><given-names>W</given-names></name>. <article-title>Economic evaluations of big data analytics for clinical decision-making: A scoping review</article-title>. <source>J Am Med Informatics Assoc</source>. <year>2020</year>;<volume>27</volume>: <fpage>1466</fpage>&#8211;<lpage>1475</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/jamia/ocaa102</pub-id><pub-id pub-id-type="pmid">32642750</pub-id><pub-id pub-id-type="pmcid">PMC7526472</pub-id></mixed-citation></ref><ref id="pone.0274276.ref154"><label>154</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Williamson</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Aponte-Hao</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mele</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lethebe</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Leduc</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Thandi</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Developing and validating a primary care EMR-based frailty definition using machine learning</article-title>. <source>Int J Popul Data Sci</source>. <year>2020</year>;<volume>5</volume>: <fpage>1344</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.23889/ijpds.v5i1.1344</pub-id><pub-id pub-id-type="pmid">32935059</pub-id><pub-id pub-id-type="pmcid">PMC7477778</pub-id></mixed-citation></ref><ref id="pone.0274276.ref155"><label>155</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Collins</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Dhiman</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Andaur Navarro</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hooft</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Reitsma</surname><given-names>JB</given-names></name>, <etal>et al</etal>. <article-title>Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence</article-title>. <source>BMJ Open</source>. <year>2021</year>;<volume>11</volume>: <fpage>e048008</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmjopen-2020-048008</pub-id><pub-id pub-id-type="pmid">34244270</pub-id><pub-id pub-id-type="pmcid">PMC8273461</pub-id></mixed-citation></ref></ref-list></back><sub-article article-type="aggregated-review-documents" id="pone.0274276.r001" specific-use="decision-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0274276.r001</article-id><title-group><article-title>Decision Letter 0</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Vathy-Fogarassy</surname><given-names initials="&#xC1;">&#193;gnes</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#169; 2023 &#193;gnes Vathy-Fogarassy</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>&#193;gnes Vathy-Fogarassy</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1371/journal.pone.0274276" id="rel-obj001" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>0</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">5 Apr 2023</named-content>
</p><p>PONE-D-22-23382A systematic review of clinical health conditions predicted by machine learning diagnostic and prognostic models trained or validated using real-world primary health care dataPLOS ONE</p><p>Dear Dr. Abdulazeem,</p><p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE&#8217;s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p><p>Please submit your revised manuscript by May 20 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at&#160;<email>plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p><p>Please include the following items when submitting your revised manuscript:<list list-type="bullet"><list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></list-item><list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></list-item><list-item><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></list-item></list></p><p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p><p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ext-link-type="uri">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link>.</p><p>We look forward to receiving your revised manuscript.</p><p>Kind regards,</p><p>&#193;gnes Vathy-Fogarassy, Ph.D.</p><p>Academic Editor</p><p>PLOS ONE</p><p>Journal Requirements:</p><p>When submitting your revision, we need you to address these additional requirements.</p><p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p><p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and</p><p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link>
</p><p>[Note: HTML markup is below. Please do not edit.]</p><p>Reviewers' comments:</p><p>Reviewer's Responses to Questions</p><p>Comments to the Author</p><p>1. Is the manuscript technically sound, and do the data support the conclusions?</p><p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p><p>Reviewer #1:&#160;Yes</p><p>Reviewer #2:&#160;Yes</p><p>**********</p><p>2. Has the statistical analysis been performed appropriately and rigorously? </p><p>Reviewer #1:&#160;N/A</p><p>Reviewer #2:&#160;N/A</p><p>**********</p><p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p><p>The <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data&#8212;e.g. participant privacy or use of data from a third party&#8212;those must be specified.</p><p>Reviewer #1:&#160;Yes</p><p>Reviewer #2:&#160;Yes</p><p>**********</p><p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p><p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p><p>Reviewer #1:&#160;No</p><p>Reviewer #2:&#160;Yes</p><p>**********</p><p>5. Review Comments to the Author</p><p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p><p>Reviewer #1:&#160;Summary</p><p>This is a useful review of machine learning methods for risk prediction of diseases or their complications using primary care databases. I&#8217;ve identified a number of issues with it, but, if these can be resolved, I would recommend publication.</p><p>Main comments</p><p>Many people will object (some strongly) to the inclusion of logistic regression here as an ML method. Some would also argue, for example, that ANNs can be just a set of logistic regressions and would therefore also be included in statistical learning rather than ML. &#8220;Classical log reg&#8221; is mentioned once, so it&#8217;s important to explain what is meant by this and by simply &#8220;log reg&#8221;.</p><p>On the same theme, I would not include the studies that used clustering or other unsupervised methods, as these are not really about risk prediction for an individual patient. If reinforcement and unsupervised ML methods, e.g., NLP have been used in pre-processing, they should be separated from the main method used to fit the model.</p><p>The tables are good. However, the accompanying text often repeats what&#8217;s in the tables in terms of how many studies were of which diagnosis or came from which country. I think this would be easier to digest if placed in an extra table instead.</p><p>Also, the text brings out some important points from a particular study but without developing it or framing it for the reader. For example, &#8220;a study reported that variations in the importance of different risk factors depend on the modelling technique [35]&#8221;. Was this the only study to do this? Is one of the goals of this paper under review to highlight such modelling issues or just to summarise the frequency of methods used? The two sentences that followed that one also illustrate the point: &#8220;Another study reported that ignoring censoring substantially underestimated risk of cardiovascular disease [43]. Also, systolic blood pressure could be used as a predictor of hospitalization or mortality [59].&#8221; It&#8217;s well known that censoring affects the estimated risk, so this sentence should be deleted. If SBP is worth mentioning, what about other predictors? There are many other such examples in other sections of the Results, which needs to be rethought.</p><p>Some reflection on WHY the reporting of methods in the studies in this review is often so limited would be useful. There have been many studies highlighting such limitations in non-ML fields that are relevant here.</p><p>Discussion: &#8220;Other drawbacks reported, similar to our findings, were underrepresentation of healthy persons and retrospective temporal dimension of the extracted predictors [142].&#8221; This is worth explaining better and unpacking with further discussion. For example, is the underrepresentation due to healthy people not attending PHC and so not being captured in the EHR? Or is something else meant here?</p><p>Discussion: &#8220;Furthermore, ML engineers must be aware of the unintended implications of their algorithms and ensure that they are created with the global and local communities in mind [145].&#8221; Again, this needs explaining and unpicking. What are the unintended implications? These could include healthcare rationing and widening of inequalities, but the authors may be thinking of something else (too). Do algorithms need to consider &#8220;global communities&#8221;? This brings me to a related point about the need for external validation of models. I would argue that external validation of a model in another country is not needed unless the model&#8217;s creators intend the model to be used overseas. Healthcare systems &#8211; and hence the populations using a particular sector and the available data &#8211; vary so much that performance would be either too poor to use or the model simply not relevant. The authors have penalised the lack of external validation perhaps unfairly. However, if what is meant by &#8220;external validation&#8221; covers another similar data set in the same country, then I&#8217;d agree that that validation would be important to do.</p><p>Minor comments</p><p>The Abstract should give the name of the risk of bias tool. &#8220;Extracted date&#8221; should be &#8220;Extracted data&#8221;. %s should be given for Alzheimer&#8217;s disease and diabetes. The Conclusions should summarise the importance / relevance of the findings rather than say it&#8217;s the first of its kind.</p><p>Introduction: &#8220;To achieve these PHC care aims, common health disorders require risk prediction for primary prevention, early diagnosis, follow-up, and timely interventions to avoid diseases exacerbations and complications.&#8221; I disagree that risk prediction is needed for all these things if it refers to risk-prediction models. Clinician training and experience is used far more than any model for diagnosis, for instance. The rationale for risk-prediction models needs to be clearly and accurately set out to help demonstrate the importance of this study.</p><p>Introduction: most EHR-type databases available to researchers are not &#8220;big data&#8221;, simply large. This is one reason why statistical learning is so common in risk-prediction models.</p><p>Methods: &#8220;Health conditions extracted were categorized according to international classification</p><p>of diseases (ICD)-10 version 2019&#8221;. How was this done for UK studies, where primary care EHRs don&#8217;t use ICD10?</p><p>Results: &#8220;Sample sizes used for training and/or validating the models across the included studies</p><p>ranged from 26 to around 4 million participants&#8221;. Is 26 right?!?</p><p>Results: &#8220;A study revealed that models can be created using only data from medical records and had prediction values of 70-80% for identifying persons who are at risk of acquiring ankylosing spondylitis (M45) [100].&#8221; Do you mean a sensitivity of 70-80%? Or PPV? Or something else?</p><p>Weng (ref 35) used CPRD, and therefore any models from it are by definition &#8211; in contrast to what Weng et al say in their paper &#8211; retrospective cohort studies. Table 1 should be amended accordingly and the other CPRD studies checked.</p><p>Discussion: &#8220;it would be advisable that models&#8217; developers propose solutions for the digital documentation systems&#8230;&#8221; Modellers are not IT or IG experts!</p><p>There are numerous minor issues with the English. Just one example is: &#8220;A few studies (n=10) compared the performance of the developed ML models to other standard reference techniques&#8221;, where &#8220;to&#8221; should be &#8220;with&#8221; (they mean different things).</p><p>Another is: &#8220;Children obesity&#8221; should be &#8220;childhood obesity&#8221;.</p><p>&#8220;Evitable&#8221; should be &#8220;avoidable&#8221;.</p><p>There are many others.</p><p>Reviewer #2:&#160;Recommendation: minor revision</p><p>This work presents a systematic review of the application of ML in the context of primary health care. Literature published between January 1990 to January 2022 is considered.</p><p>1. Is the manuscript technically sound, and do the data support the conclusions? Yes</p><p>2. Has the statistical analysis been performed appropriately and rigorously? NA</p><p>3. Have the authors made all data underlying the findings in their manuscript fully available? NA</p><p>4. Is the manuscript presented in an intelligible fashion and written in standard English? Yes</p><p>1. No insights related to algorithms applied. Any observation related to the most commonly used algorithms and the best performing ones?</p><p>2. What kind of data is usually used? Textual? Images? What kind of features?</p><p>3. What ate the current challenges in applying ML to primary health care data?</p><p>4. What are the most challenging diseases for ML prediction?</p><p>5. What kind of evaluation approaches are used?</p><p>6. Has any of the reviewed work been deployed in a real world application?</p><p>7. Quality of figures and tables need to be improved.</p><p>8. Need to discuss implications of the results.</p><p>**********</p><p>6. PLOS authors have the option to publish the peer review history of their article (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p><p>If you choose &#8220;no&#8221;, your identity will remain anonymous but your review may still be made public.</p><p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p><p>Reviewer #1:&#160;<bold>Yes:&#160;</bold>Alex Bottle</p><p>Reviewer #2:&#160;No</p><p>**********</p><p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p><p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool,&#160;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at&#160;<email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p><supplementary-material id="pone.0274276.s006" position="float" content-type="local-data" orientation="portrait"><label>Attachment</label><caption><p>Submitted filename: <named-content content-type="submitted-filename">PONE-D-22-23382.docx</named-content></p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0274276.s006.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></body></sub-article><sub-article article-type="author-comment" id="pone.0274276.r002"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0274276.r002</article-id><title-group><article-title>Author response to Decision Letter 0</article-title></title-group><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="editor-report" id="rel-obj002" xml:lang="en" ext-link-type="doi" xlink:href="10.1371/journal.pone.0274276"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="author-response-date">25 May 2023</named-content>
</p><p>Response to reviewers' comments</p><p>Reviewer #1: </p><p>Summary: This is a useful review of machine learning methods for risk prediction of diseases or their complications using primary care databases. I&#8217;ve identified a number of issues with it, but, if these can be resolved, I would recommend publication.</p><p>&#65533; Thank you for your comments, we highly appreciate your valuable feedback.</p><p>Main comments</p><p>1. Many people will object (some strongly) to the inclusion of logistic regression here as an ML method. Some would also argue, for example, that ANNs can be just a set of logistic regressions and would therefore also be included in statistical learning rather than ML. &#8220;Classical log reg&#8221; is mentioned once, so it&#8217;s important to explain what is meant by this and by simply &#8220;log reg&#8221;.</p><p>&#65533; We agree that logistic regression is not a method of machine learning but is rather counted under statistical learning. Therefore, we follow your suggestion and omitted logistic regression from the methods investigated. This did not affect the number of the included studies, however the total number of models was reduced (273 to 224 models). Subsequently, we removed this sentence &#8220;A few studies (n=10) compared the performance of the developed ML models to other standard reference techniques that were based on classical statistics, such as classical logistic and Cox regression.&#8221;</p><p>&#65533; However, we prefer to keep ANNs. Even if it is true that they can be seen as a set of logistic regressions, ANNs usually develop more complex functional relationships between predictors and outcome than logistic regression and are typically counted as machine learning models. </p><p>2. On the same theme, I would not include the studies that used clustering or other unsupervised methods, as these are not really about risk prediction for an individual patient. If reinforcement and unsupervised ML methods, e.g., NLP have been used in pre-processing, they should be separated from the main method used to fit the model.</p><p>&#65533; Clustering is not for risk prediction for individual patients. The primary studies using unsupervised models were included to identify the health conditions addressed within primary healthcare settings. But considering your valuable comment, our results regarding the unsupervised ML models would not be reliable, as many similar studies might have been missed at the literature screening stage. Hence, these studies using only unsupervised ML models were removed from the included studies (n=3, namely Alexander et al 2021, Nikolaou et al 2021, and Pikoula et al 2019).</p><p>&#65533; Regarding NLP, we removed it from the descriptive summary of the ML predictive models and rephrased the sentence to clarify its usage as a preparatory step. The sentence was corrected (Lines 205-207) as follows: &#8220;Five studies used the natural language processing (NLP) technique to handle free text clinical notes [43,45&#8211;48].&#8221;</p><p>3. The tables are good. However, the accompanying text often repeats what&#8217;s in the tables in terms of how many studies were of which diagnosis or came from which country. I think this would be easier to digest if placed in an extra table instead.</p><p>&#65533; The captions of the three tables (Tables 2-4) were meant to highlight the grouping of the primary studies as indicated in the methods section. The additional accompanying descriptive text in the &#8220;Results&#8221; section was removed. An extra panel was provided as a supplementary material to quantitatively summarize the results (S1 Panel). </p><p>4. Also, the text brings out some important points from a particular study but without developing it or framing it for the reader. For example, &#8220;a study reported that variations in the importance of different risk factors depend on the modelling technique [35]&#8221;. Was this the only study to do this? Is one of the goals of this paper under review to highlight such modelling issues or just to summarise the frequency of methods used? The two sentences that followed that one also illustrate the point: &#8220;Another study reported that ignoring censoring substantially underestimated risk of cardiovascular disease [43]. Also, systolic blood pressure could be used as a predictor of hospitalization or mortality [59].&#8221; It&#8217;s well known that censoring affects the estimated risk, so this sentence should be deleted. If SBP is worth mentioning, what about other predictors? There are many other such examples in other sections of the Results, which needs to be rethought.</p><p>&#65533; In our protocol, we planned to encompass the health conditions as well as a deeper statistical analysis of performance of the models tested and the used predictors in two manuscripts. Considering that the points you highlighted could have been quite selective and biased, we removed all these selected points. Hence, we keep this manuscript consistent with one clear outcome and maintain it as an umbrella presentation of the health conditions. Therefore, we updated all the relevant points across the manuscript accordingly. </p><p>5. Some reflection on WHY the reporting of methods in the studies in this review is often so limited would be useful. There have been many studies highlighting such limitations in non-ML fields that are relevant here.</p><p>&#65533; We highlighted this point in the &#8220;discussion&#8221; sections, lines 355-357 as follows: &#8220;Navarro and colleagues investigated this underreporting, and they claimed that the available reporting guidelines of modelling studies might be less apposite for ML models studies [141]&#8221;</p><p>6. Discussion: &#8220;Other drawbacks reported, similar to our findings, were underrepresentation of healthy persons and retrospective temporal dimension of the extracted predictors [142].&#8221; This is worth explaining better and unpacking with further discussion. For example, is the underrepresentation due to healthy people not attending PHC and so not being captured in the EHR? Or is something else meant here?</p><p>&#65533; The discussion section was re-written and reorganized for better interpretation. This point is interpreted in the &#8220;Implication of results&#8221; subsection, lines 371-375 as follows: &#8220;Well-designed and -documented repositories provide representative health data for the healthy and diseased populations are needed [140]. These data repositories might support matching the research questions of future modelling studies with the models&#8217; development and validation process for more accurate prediction.&#8221; </p><p>7. Discussion: &#8220;Furthermore, ML engineers must be aware of the unintended implications of their algorithms and ensure that they are created with the global and local communities in mind [145].&#8221; Again, this needs explaining and unpicking. What are the unintended implications? These could include healthcare rationing and widening of inequalities, but the authors may be thinking of something else (too). Do algorithms need to consider &#8220;global communities&#8221;?</p><p>&#65533; This point was also rephrased (lines 362-369). To avoid unclarity, we omitted &#8220;global and local communities.&#8221; We wrote: &#8220;Interdisciplinary collaboration among healthcare workers, developers of ML models, and creators of digital documentation systems is required. This is especially important given the increasing popularity of digitally connected health systems [5]. It is recommended to augment the participation of health professionals through the development process of the PHC predictive models to critically evaluate, assess, adopt, and challenge the validation of the models within practices. This collaboration may assist ML engineers to recognize unintended negative implications of their algorithms, such as accidentally fitting of confounders, and unintended discriminatory bias, among others, for better health outcomes [142]&#8221;</p><p>8. This brings me to a related point about the need for external validation of models. I would argue that external validation of a model in another country is not needed unless the model&#8217;s creators intend the model to be used overseas. Healthcare systems &#8211; and hence the populations using a particular sector and the available data &#8211; vary so much that performance would be either too poor to use or the model simply not relevant. The authors have penalised the lack of external validation perhaps unfairly. However, if what is meant by &#8220;external validation&#8221; covers another similar data set in the same country, then I&#8217;d agree that that validation would be important to do.</p><p>&#65533; Lack of external validation was only considered based on the CHARMS and PROBAST guidelines in the case of complete absence of validation of the model using different dataset. Those studies reporting validation of the models from different times in the same source or different datasets within the same country were considered externally validated models. To support reading clarity, this sentence was added in the &#8220;Methods&#8221; section, lines 138-141 : &#8220;External validation was considered if the model was at least validated using a dataset from a later time point in the same data source (temporal external validation) or using a different dataset from inside or outside the source country (geographical or broad external validation, respectively) [20].&#8221;</p><p>9. Minor comments</p><p>a. The Abstract should give the name of the risk of bias tool. &#8220;Extracted date&#8221; should be &#8220;Extracted data&#8221;. %s should be given for Alzheimer&#8217;s disease and diabetes.</p><p>&#65533; Corrected</p><p>b. The Conclusions should summarise the importance / relevance of the findings rather than say it&#8217;s the first of its kind.</p><p>&#65533; We updated this sentence to the following: &#8220;Our study provides a summary on the presently available ML prediction models within PHC. We draw the attention of digital health policy makers, ML models developer, and healthcare professionals for more future interdisciplinary research collaboration in this regard.&#8221; </p><p>c. Introduction: &#8220;To achieve these PHC care aims, common health disorders require risk prediction for primary prevention, early diagnosis, follow-up, and timely interventions to avoid diseases exacerbations and complications.&#8221; I disagree that risk prediction is needed for all these things if it refers to risk-prediction models. Clinician training and experience is used far more than any model for diagnosis, for instance. The rationale for risk-prediction models needs to be clearly and accurately set out to help demonstrate the importance of this study.</p><p>&#65533; We agree with your comment. We rephrased it for more clarity (Lines 46-51) as follows: &#8220;This form of health maintenance, which aims to provide constant access to high-quality care and comprehensive services, is defined and called for by the World Health Organization (WHO) global vision for PHC [2]. Clinicians&#8217; skills and experience and the further continuing professional development are fundamental to achieve these PHC care aims [3]. Additional health care improvement can be achieved by capitalizing on digital health and AI technologies.&#8221;</p><p>d. Introduction: most EHR-type databases available to researchers are not &#8220;big data&#8221;, simply large. This is one reason why statistical learning is so common in risk-prediction models.</p><p>&#65533; We rephrased this sentence and omitted the term &#8220;Big Data&#8221; and rephrased it as follows: &#8220;With the high number of patients visiting PHC and the emergence of electronic health records, substantial amounts of data are generated on daily basis.&#8221;</p><p>e. Methods: &#8220;Health conditions extracted were categorized according to international classification of diseases (ICD)-10 version 2019&#8221;. How was this done for UK studies, where primary care EHRs don&#8217;t use ICD10?</p><p>&#65533; We updated the explanation of this point in the &#8220;Methods&#8221; section, Lines 119-122, as follows: &#8220;This coding system was selected because it is applied by at least 120 countries across the globe [24]. Considering the countries that apply different coding systems, we used the explicit names of the health condition mentioned in the primary studies included to match them to the closest ICD-10 codes.&#8221;</p><p>f. Results: &#8220;Sample sizes used for training and/or validating the models across the included studies ranged from 26 to around 4 million participants&#8221;. Is 26 right?!?</p><p>&#65533; This study (Levy et al 2018) has the lowest populations. The training data were from 49 populations while the external validation data were only 26. We updated it to the total populations of the study (75) in line 69. </p><p>g. &#8220;A study revealed that models can be created using only data from medical records and had prediction values of 70-80% for identifying persons who are at risk of acquiring ankylosing spondylitis (M45) [100].&#8221; Do you mean a sensitivity of 70-80%? Or PPV? Or something else?</p><p>&#65533; This sentence was deleted for the reason mentioned in response to point number 4.</p><p>h. Weng (ref 35) used CPRD, and therefore any models from it are by definition &#8211; in contrast to what Weng et al say in their paper &#8211; retrospective cohort studies. Table 1 should be amended accordingly and the other CPRD studies checked.</p><p>&#65533; All the studies rechecked and updated accordingly in the tables and the relevant paragraphs.</p><p>i. Discussion: </p><p>&#65533; The discussion section was re-written and reorganized for better interpretation. </p><p>j. &#8220;it would be advisable that models&#8217; developers propose solutions for the digital documentation systems&#8230;&#8221; Modellers are not IT or IG experts!</p><p>&#65533; The sentence was unclear and we omitted it.</p><p>k. There are numerous minor issues with the English. Just one example is: &#8220;A few studies (n=10) compared the performance of the developed ML models to other standard reference techniques&#8221;, where &#8220;to&#8221; should be &#8220;with&#8221; (they mean different things). Another is: &#8220;Children obesity&#8221; should be &#8220;childhood obesity&#8221;., &#8220;Evitable&#8221; should be &#8220;avoidable&#8221;. There are many others.</p><p>&#65533; Corrected. The native English author SW. applied further language improvement.</p><p>Reviewer #2: </p><p>Recommendation: minor revision</p><p>This work presents a systematic review of the application of ML in the context of primary health care. Literature published between January 1990 to January 2022 is considered.</p><p>1. No insights related to algorithms applied. Any observation related to the most commonly used algorithms and the best performing ones?</p><p>&#65533; As this manuscript&#8217;s main objective was to highlight the health conditions targeted by the primary studies, we did not present the statistical estimation of the model&#8217;s performance for the reported models. However, we had already extracted such results to be presented with deeper analysis in a more homogenous and cohesive manner in another manuscript for some health conditions.</p><p>2. What kind of data is usually used? Textual? Images? What kind of features?</p><p>&#65533; We added a paragraph to briefly highlight the categories features/ predictors we found, lines 200-207, as follows: &#8220;A variety of predictors were described across the studies. Demographic characteristics and clinical picture of the health conditions were the most frequently found predictors. Medications, comorbidities, and blood tests performed within primary care unit were reported. Predictors, such as blood test results and imaging results performed within secondary and tertiary health care were additionally reported in some of the individual studies. Referral documentation and clinical notes taken by health care personnel were also reported. Five studies used the natural language processing (NLP) technique to handle free text clinical notes [43,45&#8211;48].&#8221;</p><p>3. What ate the current challenges in applying ML to primary health care data?</p><p>&#65533; The &#8220;Discussion&#8221; section was re-written and reorganized to highlight the current challenges that we identified. </p><p>4. What are the most challenging diseases for ML prediction?</p><p>&#65533; To present such a result, we planned, according to our protocol, to present a deeper analysis of the models and the predictors, tackling the challenges faced by the developers as well as their final conclusions regarding their models. This will be in the subsequent manuscript for a cohesive and consistent reporting of the results according to the ICD-10 category.</p><p>5. What kind of evaluation approaches are used?</p><p>&#65533; As this manuscript&#8217;s main objective is to highlight the health conditions targeted by the primary studies, we did not report the results of the evaluation approaches. To avoid selective and biased results reporting as well, we removed the relevant text. Please see the answer of comment number 4 in the comments of reviewer 1.</p><p>6. Has any of the reviewed work been deployed in a real world application?</p><p>&#65533; According to our knowledge and analysis of the full text of the included studies, only four studies claimed a real-time application. This was updated in lines 189-191. </p><p>7. Quality of figures and tables need to be improved.</p><p>&#65533; Done</p><p>8. Need to discuss implications of the results.</p><p>&#65533; The discussion section was re-written and reorganized to highlight the implication of results, lines 360-385.</p><supplementary-material id="pone.0274276.s007" position="float" content-type="local-data" orientation="portrait"><label>Attachment</label><caption><p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers.docx</named-content></p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0274276.s007.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></body></sub-article><sub-article article-type="aggregated-review-documents" id="pone.0274276.r003" specific-use="decision-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0274276.r003</article-id><title-group><article-title>Decision Letter 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Vathy-Fogarassy</surname><given-names initials="&#xC1;">&#193;gnes</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#169; 2023 &#193;gnes Vathy-Fogarassy</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>&#193;gnes Vathy-Fogarassy</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="reviewed-article" id="rel-obj003" xml:lang="en" ext-link-type="doi" xlink:href="10.1371/journal.pone.0274276"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">19 Jun 2023</named-content>
</p><p>PONE-D-22-23382R1A systematic review of clinical health conditions predicted by machine learning diagnostic and prognostic models trained or validated using real-world primary health care dataPLOS ONE</p><p>Dear Dr. Abdulazeem,</p><p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE&#8217;s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p><p>Please submit your revised manuscript by Aug 03 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at&#160;<email>plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p><p>Please include the following items when submitting your revised manuscript:<list list-type="bullet"><list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></list-item><list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></list-item><list-item><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></list-item></list></p><p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p><p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ext-link-type="uri">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link>.</p><p>We look forward to receiving your revised manuscript.</p><p>Kind regards,</p><p>&#193;gnes Vathy-Fogarassy, Ph.D.</p><p>Academic Editor</p><p>PLOS ONE</p><p>Additional Editor Comments:</p><p>Dear Authors,</p><p>For the corrected manuscript, Reviewer #2 gave the following feedback:</p><p>"Some of my concerns were not addressed in your response."</p><p>Please take into account all the reviewer's suggestions and requests, otherwise we cannot accept the article.</p><p>Best regards!</p><p>[Note: HTML markup is below. Please do not edit.]</p><p>Reviewers' comments:</p><p>Reviewer's Responses to Questions</p><p>

<bold>Comments to the Author</bold>
</p><p>1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the &#8220;Comments to the Author&#8221; section, enter your conflict of interest statement in the &#8220;Confidential to Editor&#8221; section, and submit your "Accept" recommendation.</p><p>Reviewer #1:&#160;All comments have been addressed</p><p>Reviewer #2:&#160;(No Response)</p><p>**********</p><p>2. Is the manuscript technically sound, and do the data support the conclusions?</p><p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p><p>Reviewer #1:&#160;Yes</p><p>Reviewer #2:&#160;Partly</p><p>**********</p><p>3. Has the statistical analysis been performed appropriately and rigorously? </p><p>Reviewer #1:&#160;Yes</p><p>Reviewer #2:&#160;N/A</p><p>**********</p><p>4. Have the authors made all data underlying the findings in their manuscript fully available?</p><p>The <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data&#8212;e.g. participant privacy or use of data from a third party&#8212;those must be specified.</p><p>Reviewer #1:&#160;Yes</p><p>Reviewer #2:&#160;Yes</p><p>**********</p><p>5. Is the manuscript presented in an intelligible fashion and written in standard English?</p><p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p><p>Reviewer #1:&#160;Yes</p><p>Reviewer #2:&#160;Yes</p><p>**********</p><p>6. Review Comments to the Author</p><p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p><p>Reviewer #1:&#160;The authors have responded well to my comments, and in my opinion the ms is much improved. I am happy to recommend it for publication.</p><p>Reviewer #2:&#160;(No Response)</p><p>**********</p><p>7. PLOS authors have the option to publish the peer review history of their article (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p><p>If you choose &#8220;no&#8221;, your identity will remain anonymous but your review may still be made public.</p><p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p><p>Reviewer #1:&#160;No</p><p>Reviewer #2:&#160;No</p><p>**********</p><p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p><p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool,&#160;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at&#160;<email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p></body></sub-article><sub-article article-type="author-comment" id="pone.0274276.r004"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0274276.r004</article-id><title-group><article-title>Author response to Decision Letter 1</article-title></title-group><related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1371/journal.pone.0274276" id="rel-obj004" related-article-type="editor-report"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>2</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="author-response-date">21 Aug 2023</named-content>
</p><p>Revision 2: Response to Reviewers' Comments</p><p>Response to Reviewer #2: </p><p>We would like to thank you for your valuable comments that helped us improve our manuscript. We are very eager to properly address all your comments. Despite that, it seems that we did not address some of your comments. We apologize for this. </p><p>We now addressed all comments in detail, restructured parts of the discussion and added a new table (S2 Table) to the supplement addressing the characteristics of all ML predictive models included in the manuscript (see below).</p><p>1. No insights related to algorithms applied. Any observation related to the most commonly used algorithms and the best performing ones?</p><p>&#65533; We addressed this point in our manuscript through presenting the advantages and disadvantages of the included models and related that to our results across the manuscript:</p><p>o We referred to it in the introduction section in page 3, lines 60-61 as follows &#8220;The variety of ML prediction models&#8217; characteristics provide broader opportunities to support the healthcare practice.&#8221;</p><p>o We presented more information regarding the advantages and disadvantages of the models included in a new supplementary Table S2. We referred to it in our results section page 10, lines 200-201 as follows: &#8220;Supplementary table (S2 Table) presents advantages and disadvantages of these models in addition to further descriptive information of the included studies.&#8221;</p><p>o In the discussion section, we discussed the most commonly used models in page 20, line 323-325 as follows: &#8220;In 106 observational studies, we identified 42 health conditions targeted by 207 ML prediction models, of which 38% were random forest and SVM. The included models used PHC data documented over the past 40 years for a total of 22.7 million patients.&#8221;. Please also see answer to question 2 below.</p><p>o Furthermore, we related our results to the advantages of these models and the potential benefit of it within the primary healthcare and referred to it in page 22, lines 360-369 as follows: &#8220;Models that are known for their high prediction accuracy, such as random forest and SVM might support better health outcomes when developed using high quality health data [140]. Additionally, the variety of the ML prediction models characteristics provide opportunities to improve healthcare practice. Using large data documented as electronic health records, random forest models and ensemble models such as boosting models have the ability to handle large datasets with numerous predictors variables [141]. Artificial neural network can also perform complex images processing that can boost the primary health care services [141]. Furthermore, SVM and decision tree models can provide nonlinear solutions, thus will support our understanding of complex and dynamic diseases for earlier health conditions prediction [142].&#8221; </p><p>2. What kind of data is usually used? Textual? Images? What kind of features?</p><p> We added a paragraph to highlight the data used in page 10, lines 207-2014, as follows: &#8220;The data used to develop the models were called predictors, features, or variables across the included studies. These data were mostly textual. Demographic characteristics and clinical picture of the health conditions were the most frequently found data. Medications, comorbidities, and blood tests performed within primary care unit were reported. Data, such as blood test results and imaging results performed within secondary and tertiary health care were additionally reported in some of the individual studies. Referral documentation and clinical notes taken by health care personnel were also reported. Five studies used the natural language processing (NLP) technique to handle free text clinical notes [43,45&#8211;48].&#8221;</p><p>3. What are the current challenges in applying ML to primary health care data?</p><p>&#65533; We highlighted some of the current challenges in applying ML to PHC data in the discussion section and presented it in context with our results in the subsection &#8220;Results in perspective&#8221; in two places:</p><p>o in page 21, lines 344-352 as follows: &#8220;The coding system used in health records does not universally follow the same criteria for all diseases, posing challenges for the consistency of models&#8217; performance [137]. Moreover, the lack of globally standardized definitions and terminology of diseases and the wide variability of the services provided across different health systems further limit the effectiveness of the models [137]. For example, uncoded free-text clinical notes as well as using &#8216;race&#8217; and &#8216;ethnicity&#8217; or &#8216;suicide&#8217; and &#8216;suicide attempts&#8217; to be documented as a single input can affect the predictive power of the models [138]. Other drawbacks reported include underrepresentation of healthy persons, retrospective temporal dimension of predictors, and the absence of confirmatory diagnostic services in PHC pose significant limitations [140, 14 1].&#8221; </p><p>o in page 22, lines 378-386, as follows &#8220;Health care professionals are fundamental to the process of implementing and integrating ML prediction models in their healthcare practice. Despite that, our review did not report outcomes related to healthcare professionals. Significant variability of opinions on the utilization of ML in PHC among primary health care providers hinder its acceptance. Furthermore, the black-box nature of ML prediction models precludes the clinical interpretability of models&#8217; outcomes. Additional workload and training are needed to implement such technology in the routine practice. Trust, data protection, and ethical and clinical responsibility legislation are further intractable issues that represent major obstacles toward ML prediction models implementation [5].&#8221;</p><p>o In page 24, lines 410-413, as follows &#8220;Despite the additional burden, it is beneficial also to continuously assess the potential significance of models, such as improved health outcomes, reduced medical errors, increased professional effectiveness and productivity, and enhanced patients&#8217; quality of life [147].&#8221;</p><p>4. What are the most challenging diseases for ML prediction?</p><p>&#65533; We addressed this point in page 22, lines &#8220;370-377&#8221; as follows: &#8220;Nature of diseases append further challenges. The most challenging diseases for ML prediction are multifaceted long-term health conditions, such as DM, that are influenced by combination of genetic, environmental, and lifestyle factors. The complex health conditions further tangle the models, making it harder to identify accurate predictive patterns. Furthermore, the subjective nature of symptoms, especially symptoms related to mental health disorders, pose additive challenges toward ML models accuracy. Rare diseases, if documented, often suffer from limited data availability, leading to difficulty to train ML models effectively [143].&#8221;</p><p>5. What kind of evaluation approaches are used?</p><p>&#65533; We addressed this point in page 10, lines 201-206 as follows: &#8220;The most frequently reported evaluation approach of models&#8217; performance was the area under the receiver operating characteristic curve (AUROC), which was reported as &#8220;good&#8221; to &#8220;moderate&#8221; models performance in 62 studies. One study reported the performance measures using decision analysis curve [32]. Other evaluation approaches were reported across the included studies, such as calculating sensitivity, specificity, predictive values, and accuracy.&#8221;</p><p>6. Has any of the reviewed work been deployed in a real world application?</p><p>&#65533; We referred to this point in page 9, lines 190-192 &#8220;Despite all studies included used real-world patients' data to develop and/or validate the ML models, four studies reported applying the models develop in real-world primary health care settings [127,128, 130, 131].&#8221; </p><p>7. Quality of figures and tables need to be improved.</p><p>&#65533; We improved the quality of all our tables and figure by proper reformatting for font, spacing, and colours.</p><p>8. Need to discuss implications of the results.</p><p>&#65533; The discussion section was re-written and reorganized to highlight the implication of results. We added a subsection in pages 23-24, lines 393-422 as follows &#8220;Implication of results and recommendation for future contributions: This review provided a comprehensive outline of ML prediction models in PHC and raises important considerations for future research and implementation of this technology in PHC settings. Interdisciplinary collaboration among health care workers, developers of ML models, and creators of digital documentation systems is required. This is especially important given the increasing popularity of digitally connected health systems [5]. It is recommended to augment the participation of health professionals through the development process of the PHC predictive models to critically evaluate, assess, adopt, and challenge the validation of the models within practices. This collaboration may assist ML engineers to recognize unintended negative implications of their algorithms, such as accidentally fitting of confounders, and unintended discriminatory bias, among others, for better health outcomes [146]. Health care systems need to provide comprehensive population health data repositories as an enabler for medical analyses [137]. Well-designed and -documented repositories which provide representative health data for the healthy and diseased populations are needed [137, 140]. These high quality data repositories might provide future modelling studies with data that match the studies&#8217; clinical research questions for more accurate prediction. Further ML prediction studies are needed to target more health conditions using PHC data. Despite being challenging, it is beneficial to early assess the potential significance of models, such as improved health outcomes, reduced medical errors, increased professional effectiveness and productivity, and enhanced patients&#8217; quality of life [147]. It is recommended to follow reporting guidelines for producing valid and reproducible ML modelling studies. Developing robust frameworks to enable the adoption and integration of ML models in the routine practice is also essential for effective transition from conventional health care systems to digital health [148,149]. Sophisticated technical infrastructure and strong academic and governmental support are essential for promoting and supporting long-term and broad-reaching PHC ML-based services [138,150]. However, balanced arguments [151,152] regarding the potential benefits and limitations of ML models support better health care without overestimating or hampering the use of such technology. It is also suggested to integrate the basic understanding of ML concepts and techniques in education programs for health science and medical students.&#8221;</p><supplementary-material id="pone.0274276.s008" position="float" content-type="local-data" orientation="portrait"><label>Attachment</label><caption><p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers-R2.docx</named-content></p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0274276.s008.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></body></sub-article><sub-article article-type="editor-report" id="pone.0274276.r005" specific-use="decision-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0274276.r005</article-id><title-group><article-title>Decision Letter 2</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Vathy-Fogarassy</surname><given-names initials="&#xC1;">&#193;gnes</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#169; 2023 &#193;gnes Vathy-Fogarassy</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>&#193;gnes Vathy-Fogarassy</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1371/journal.pone.0274276" id="rel-obj005" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>2</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">29 Aug 2023</named-content>
</p><p>A systematic review of clinical health conditions predicted by machine learning diagnostic and prognostic models trained or validated using real-world primary health care data</p><p>PONE-D-22-23382R2</p><p>Dear Dr. Abdulazeem,</p><p>We&#8217;re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p><p>Within one week, you&#8217;ll receive an e-mail detailing the required amendments. When these have been addressed, you&#8217;ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p><p>An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.editorialmanager.com/pone/" ext-link-type="uri">http://www.editorialmanager.com/pone/</ext-link>, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <email>authorbilling@plos.org</email>.</p><p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they&#8217;ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email>onepress@plos.org</email>.</p><p>Kind regards,</p><p>&#193;gnes Vathy-Fogarassy, Ph.D.</p><p>Academic Editor</p><p>PLOS ONE</p></body></sub-article><sub-article article-type="editor-report" id="pone.0274276.r006" specific-use="acceptance-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0274276.r006</article-id><title-group><article-title>Acceptance letter</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Vathy-Fogarassy</surname><given-names initials="&#xC1;">&#193;gnes</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#169; 2023 &#193;gnes Vathy-Fogarassy</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>&#193;gnes Vathy-Fogarassy</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1371/journal.pone.0274276" id="rel-obj006" related-article-type="reviewed-article"/></front-stub><body><p>
<named-content content-type="letter-date">31 Aug 2023</named-content>
</p><p>PONE-D-22-23382R2 </p><p>A systematic review of clinical health conditions predicted by machine learning diagnostic and prognostic models trained or validated using real-world primary health care data </p><p>Dear Dr. Abdulazeem:</p><p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. </p><p>If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <email>onepress@plos.org</email>.</p><p>If we can help with anything else, please email us at <email>plosone@plos.org</email>. </p><p>Thank you for submitting your work to PLOS ONE and supporting open access. </p><p>Kind regards, </p><p>PLOS ONE Editorial Office Staff</p><p>on behalf of</p><p>Dr. &#193;gnes Vathy-Fogarassy </p><p>Academic Editor</p><p>PLOS ONE</p></body></sub-article></article></pmc-articleset>